Alfa Chemistry (Page 428) @ ChemBuyersGuide.com, Inc.

CD122/IL2RB Protein, Human, Recombinant (His & Avi)
RHC-CD-2662
27.5 kDa (predicted). Due to glycosylation, the pr
RP5-1170K4.6, p75, P70-75, IL2RB, IL-2R subunit +¦, IL-2R subunit beta, IL-2 R +¦/CD122, IL-2 R +¦, IL-2 R beta, IL-15 R +¦, IL-15 R beta, CD122

CD122/IL2RB Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-0580
28.73 kDa (predicted); 39 kDa (reducing conditions
P70-75, interleukin 2 receptor, +¦, interleukin 2 receptor, beta, IL-15RB, IL15RB, CD122

CD122/IL2RB Protein, Human, Recombinant (His)
RHC-CD-0421
26 kDa (predicted)
P70-75, interleukin 2 receptor, +¦, interleukin 2 receptor, beta, IL-15RB, IL15RB, CD122

CD122/IL2RB Protein, Human, Recombinant (mFc)
RHC-RP-0872
51 kDa (predicted)
P70-75, interleukin 2 receptor, +¦, interleukin 2 receptor, beta, IL-15RB, IL15RB, CD122

CD122/IL2RB Protein, Mouse, Recombinant (hFc)
RHC-CD-0451
51.76 kDa (predicted)
p70, interleukin 2 receptor, +¦, interleukin 2 receptor, beta, Il-2R+¦, Il-2Rbeta, Il-2/15R+¦, Il-2/15Rbeta, IL-15R+¦, IL15R+¦, IL-15Rbeta, IL15Rbeta, CD122

CD122/IL2RB Protein, Mouse, Recombinant (His)
RHC-CD-0449
26.5 kDa (predicted); 45-54 kDa (reducing conditio
p70, interleukin 2 receptor, +¦, interleukin 2 receptor, beta, Il-2R+¦, Il-2Rbeta, Il-2/15R+¦, Il-2/15Rbeta, IL-15R+¦, IL15R+¦, IL-15Rbeta, IL15Rbeta, CD122

CD122/IL2RB Protein, Rat, Recombinant (His)
RHC-RP-0783
26.4 kDa (predicted)
interleukin 2 receptor, +¦, interleukin 2 receptor, beta

CD122/IL2RB Protein, Rhesus, Recombinant (hFc)
RHC-RP-0874
51.4 kDa (predicted)
interleukin 2 receptor, +¦, interleukin 2 receptor, beta

CD122/IL2RB Protein, Rhesus, Recombinant (His)
RHC-CD-0473
26.1 kDa (predicted)
interleukin 2 receptor, +¦, interleukin 2 receptor, beta

CD123 Monoclonal Antibody (6H6), Biotin-Conjugate
BR00000050

CD123 Protein, Cynomolgus, Recombinant (His)
RHC-CD-1468
50-65 kDa (reducing condition)
Interleukin-3 receptor subunit +¦, Interleukin-3 receptor subunit alpha, IL-3R-+¦, IL-3R-alpha, IL-3RA, IL-3R subunit +¦, IL-3R subunit alpha, IL-3 receptor subunit +¦, IL-3 receptor subunit alpha

CD126 Monoclonal Antibody (B-R6), Biotin-Conjugate
BR00001117

CD127 Monoclonal Antibody (A7R34), Biotin-Conjugate
BR00000150

CD127 Monoclonal Antibody (eBioRDR5), Biotin-Conjugate
BR00000213

CD13 Monoclonal Antibody (WM15), Biotin-Conjugate
BR00000786

CD130 (GP130) Monoclonal Antibody (AN-G30), Biotin-Conjugate
BR00000439

CD130 Polyclonal Antibody, Biotin-Conjugate
BR00002696

CD131 Monoclonal Antibody (1C1), Biotin-Conjugate
BR00000355

CD131 Protein, Human, Recombinant (His)
RHC-CD-2527
50 kDa (predicted); 50-55 kDa (reducing conditions
SMDP5, IL5RB, IL3RB, colony stimulating factor 2 receptor, +¦, low-affinity (granulocyte-macrophage), colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage), CDw131, CD131

CD131 Protein, Rat, Recombinant (hFc)
RHC-CD-2536
75.1 kDa (predicted); 123 and 89 kDa (reducing con
colony stimulating factor 2 receptor, +¦, low-affinity (granulocyte-macrophage), colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)

CD132 Monoclonal Antibody (TUGh4), Biotin-Conjugate
BR00000440

CD132 Monoclonal Antibody (TUGm2), Biotin-Conjugate
BR00000797

CD133 (Prominin-1) Monoclonal Antibody (13A4), Biotin-Conjugate
BR00000138

CD133/PROM1 Protein, Mouse, Recombinant (His & SUMO)
RHC-CD-3475
48.5 kDa (predicted)
Proml1, Prominin-like protein 1, Prominin-1, Prom1, Prom, CD133, Antigen AC133 homolog

CD133/PROM1 Protein, Rat, Recombinant (His)
RHC-CD-3532
37.10 kDa (predicted); 47-57 kDa (reducing conditi
prominin 1

CD133/PROM1 Protein, Rat, Recombinant (mFc)
RHC-CD-3371
60 kDa (predicted); 67 and 34 kDa (reducing condit
prominin 1

CD133/PROM1 Protein-VLP, Human, Recombinant (His)
RHC-CD-3313
96.7 kDa (predicted)
Proml1, Prominin-like protein 1, Prominin-1, Prom1, Prom, CD133, Antigen AC133 homolog

CD134/OX40L receptor Polyclonal Antibody, Biotin-Conjugate
BR00002171

CD135 (Flt3) Monoclonal Antibody (A2F10), Biotin-Conjugate
BR00000214

CD137 (4-1BB) Monoclonal Antibody (17B5), Biotin-Conjugate
BR00000241

CD137 Ligand (4-1BB Ligand) Monoclonal Antibody (TKS-1), Biotin-Conjugate
BR00000345

CD137 Polyclonal Antibody, Biotin-Conjugate
BR00000513

CD137/4-1BB/TNFRSF9 Monoclonal Antibody (4-1BB/3201), Biotin-Conjugate
BR00001399

CD137:CD137L[Biotinylated] Inhibitor Screening Assay Kit
BR00028200
4-1BB, Tumor Necrosis Factor Receptor Superfamily member 9, TNFRSF9, ILA, 4-1BB ligand, 4-1BBL, tumor necrosis factor ligand superfamily member 9, TNFSF9

CD137[Biotinylated]:CD137L Inhibitor Screening Assay Kit
BR00028184
4-1BB, Tumor Necrosis Factor Receptor Superfamily member 9, TNFRSF9, ILA, 4-1BB ligand, 4-1BBL, tumor necrosis factor ligand superfamily member 9, TNFSF9, activity assay kit

CD137L/4-1BBL/TNFSF9 Monoclonal Antibody (CD137L/1547), Biotin-Conjugate
BR00001478

CD14 (soluble) Polyclonal Antibody, Biotin-Conjugate
BR00000587

CD14 HUMAN
IAR4248411

CD14 Monoclonal Antibody (61D3), Biotin-Conjugate
BR00000023

CD14 Monoclonal Antibody (MEM-15), Biotin-Conjugate
BR00000835

CD14 Monoclonal Antibody (MEM-18), Biotin-Conjugate
BR00000767

CD14 Monoclonal Antibody (Sa2-8), Biotin-Conjugate
BR00000173

CD14 Monoclonal Antibody (TuK4), Biotin-Conjugate
BR00000960

CD14 Protein, Cynomolgus, Recombinant (His)
RHC-CD-2246
36.5 kDa (predicted); 44-48 kDa (reducing conditio
CD14 molecule, CD14

CD14 Protein, Human, Recombinant (hFc)
RHC-CD-2399
62.4 kDa (predicted); 75-85 kDa (reducing conditio
monocyte differentiation antigen CD14, CD14 molecule, CD14 antigen

CD14 Protein, Human, Recombinant (His)
RHC-CD-1838
36.5 kDa (predicted); 45 kDa (reducing condition,
monocyte differentiation antigen CD14, CD14 molecule, CD14 antigen

CD14 Protein, Mouse, Recombinant (His & hFc)
RHC-CD-2109
63.5 kDa (predicted); 85-95 kDa (reducing conditio
CD14 molecule, CD14

CD14 Protein, Mouse, Recombinant (His)
RHC-CD-1903
36.8 kDa (predicted); 45-50 kDa (reducing conditio
CD14 molecule, CD14

CD14 Protein, Rat, Recombinant (hFc)
RHC-CD-2494
62.2 kDa (predicted); 72 kDa (reducing conditions)
CD14 molecule, CD14

CD14 Protein, Rat, Recombinant (His)
RHC-CD-2212
36.7 kDa (predicted)
CD14 molecule, CD14

CD140a (PDGFRA) Monoclonal Antibody (APA5), Biotin-Conjugate
BR00000017

CD140b (PDGFRB) Monoclonal Antibody (APB5), Biotin-Conjugate
BR00000122

CD144 (VE-cadherin) Monoclonal Antibody (16B1), Biotin-Conjugate
BR00000186

CD144 (VE-cadherin) Monoclonal Antibody (eBioBV13 (BV13)), Biotin-Conjugate
BR00000163

CD146 Monoclonal Antibody (C264), Biotin-Conjugate
BR00001189

CD146/MCAM Protein, Human, Recombinant (hFc)
RHC-CD-2968
86.4 kDa (predicted); 120-130 kDa (reducing condit
MUC18, melanoma cell adhesion molecule, CD146

CD146/MCAM Protein, Human, Recombinant (His)
RHC-CD-2947
61.3 kDa (predicted); 80-90 kDa (reducing conditio
MUC18, melanoma cell adhesion molecule, CD146

CD146/MCAM Protein, Human, Recombinant (His), Biotinylated
RHC-CD-2971
61.3 kDa (predicted); 88.9 kDa (reducing condition
MUC18, melanoma cell adhesion molecule, CD146

CD146/MCAM Protein, Mouse, Recombinant (His)
RHC-CD-2931
61.3 kDa (predicted); 90-100 kDa (reducing conditi
s-gicerin, s-endo, Muc18, melanoma cell adhesion molecule, CD149, CD146, AV025631, 1-gicerin

CD147 (soluble) Monoclonal Antibody (MEM-M6/1), Biotin-Conjugate
BR00000833

CD147 HUMAN
IAR42413204

CD147 Monoclonal Antibody (OX114), Biotin-Conjugate
BR00000900

CD148 Monoclonal Antibody (MEM-CD148/05), Biotin-Conjugate
BR00000782

CD15 Monoclonal Antibody (HI98), Biotin-Conjugate
BR00000055

CD150 Monoclonal Antibody (9D1), Biotin-Conjugate
BR00000705

CD152 (CTLA-4) Monoclonal Antibody (14D3), Biotin-Conjugate
BR00000468

CD152 (CTLA-4) Monoclonal Antibody (UC10-4B9), Biotin-Conjugate
BR00000474

CD152 (HUMAN): FC (HUMAN) (NON-LYTIC)
IAR42413212

CD152/FC CHIMERA, CYTOLYTIC FROM MOUSE
IAR42413145

CD152/FC CHIMERA, NON-CYTOLYTIC FROM MOUSE
IAR42414748

CD1530
CAS:107430-66-0
AP107430660
398.49

CD154 (CD40 Ligand) (soluble) Polyclonal Antibody, Biotin-Conjugate
BR00000508

CD154 (CD40 Ligand) Monoclonal Antibody (MK13A4), Biotin-Conjugate
BR00000814

CD154 (CD40 Ligand) Monoclonal Antibody (MR1), Biotin-Conjugate
BR00000319

CD155 HUMAN
IAR42413205

CD155 Monoclonal Antibody (D171), Biotin-Conjugate
BR00000617

CD155/PVR Protein, Human, Recombinant (hFc & Avi), Biotinylated
RHC-CD-2903
63.6 kDa (predicted); 91.4 kDa (reducing condition
TAGE4, PVS, poliovirus receptor, Necl-5, NECL5, HVED, CD155

CD155/PVR Protein, Human, Recombinant (hFc)
RHC-CD-2871
61.8 kDa (predicted); 95-105 kDa (reducing conditi
TAGE4, PVS, poliovirus receptor, Necl-5, NECL5, HVED, CD155

CD155/PVR Protein, Human, Recombinant (His & Avi)
RHC-CD-2887
38 kDa (predicted). Due to glycosylation, the prot
Tage4, PVSFLJ25946, PVS, PVR, nectin-like 5, Necl-5, NECL5, HVED, FLJ25946, CD155

CD155/PVR Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-2914
38.3 kDa (predicted)
TAGE4, PVS, poliovirus receptor, Necl-5, NECL5, HVED, CD155

CD155/PVR Protein, Human, Recombinant (His)
RHC-CD-2987
36.5 kDa (predicted); 60-65 kDa (reducing conditio
TAGE4, PVS, poliovirus receptor, Necl-5, NECL5, HVED, CD155

CD155/PVR Protein, Mouse, Recombinant (hFc & Avi), Biotinylated
RHC-CD-2870
62.9 kDa (predicted)
Tage4, Taa1, PVS, poliovirus receptor, necl-5, mE4, HVED, D7Ertd458e, CD155, 3830421F03Rik

CD155/PVR Protein, Mouse, Recombinant (His)
RHC-CD-2902
28 kDa (predicted); 60-65 kDa (reducing condition,
Tage4, Taa1, PVS, poliovirus receptor, necl-5, mE4, HVED, D7Ertd458e, CD155, 3830421F03Rik

CD155/PVR Protein, Mouse, Recombinant (mFc)
RHC-CD-2869
60.78 kDa (predicted)
Tage4, Taa1, PVS, poliovirus receptor, necl-5, mE4, HVED, D7Ertd458e, CD155, 3830421F03Rik

CD155/PVR Protein, Rat, Recombinant (His)
RHC-CD-2982
35.8 kDa (predicted); 55-65 kDa (reducing conditio
poliovirus receptor

CD155/PVR Protein, Rhesus, Recombinant (His)
RHC-CD-2945
35.8 kDa (predicted)
poliovirus receptor

CD157 Protein (Cynomolgus, HEK293, His-tag)
NZs001688
ADP-ribosyl cyclase; BST1; Cyclic ADP-ribose hydrolase 2; CD157

CD157 Protein, Human, Recombinant (hFc)
RHC-CD-1376
75 kDa (reducing condition)
Cyclic ADP-ribose hydrolase 2, CD157, cADPr hydrolase 2, BST-1, Bone marrow stromal antigen 1, ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2, ADP-ribosyl cyclase 2

CD157 Protein, Human, Recombinant (His)
RHC-CD-1770
31.4 kDa (predicted); 38-43 kDa (reducing conditio
CD157, bone marrow stromal cell antigen 1

CD157 Protein, Mouse, Recombinant (His)
RHC-CD-1399
30.9 kDa (predicted); 37, 40 and 44 kDa (reducing
Ly65, CD157, Bsta1, BP-3, Bp3, bone marrow stromal cell antigen 1, A530073F09, 114/A10

CD157 Protein, Rat, Recombinant (hFc)
RHC-CD-1492
56.8 kDa (predicted); 67 kDa (reducing conditions)
bone marrow stromal cell antigen 1

CD157 Protein, Rat, Recombinant (His)
RHC-CD-1542
31.2 kDa (predicted); 38-42 kDa (reducing conditio
bone marrow stromal cell antigen 1

CD16 Monoclonal Antibody (3G8), Biotin-Conjugate
BR00000941

CD16 Monoclonal Antibody (eBioCB16 (CB16)), Biotin-Conjugate
BR00000009

CD16 Monoclonal Antibody (J5511), Biotin-Conjugate
BR00001127

CD16 Monoclonal Antibody (MEM-154), Biotin-Conjugate
BR00000769

CD16 Protein, Cynomolgus, Recombinant (His)
RHC-RP-1921
23.1 kDa (predicted). Due to glycosylation, the pr
IMD20, IgG Fc receptor III, IGFR3, Fc-+¦ RIII, FCRIIIA, FcRIII, FCR-10, FcgRIII, FCGR3, Fc-gamma RIII, FCG3, Fc +¦ RIIB, CD16A, CD16

CD16/CD32 Monoclonal Antibody (93), Biotin-Conjugate
BR00000235

CD16/CD32 Monoclonal Antibody (KT1632), Biotin-Conjugate
BR00000907

CD16/FCGR3 Protein, Mouse, Recombinant (aa 32-215, His)
RHC-CD-1856
22.6 kDa (predicted); 35-44 kDa (reducing conditio
Fc receptor, IgG, low affinity III, CD16

CD16/FCGR3 Protein, Mouse, Recombinant (His & Avi), Biotinylated
RHC-CD-2430
24.4 kDa (predicted)
Fc receptor, IgG, low affinity III, CD16

CD16/FCGR3 Protein, Mouse, Recombinant (His)
RHC-CD-2342
35-40 kDa (reducing condition)
Low affinity immunoglobulin +¦ Fc region receptor III, Low affinity immunoglobulin gamma Fc region receptor III, IgG Fc receptor III, FcRIII, Fcgr3, Fc +¦ Receptor III, Fc gamma Receptor III, CD-antigen 16, CD16

CD16/FCGR3 Protein, Rhesus, Recombinant (His & Avi)
RHC-CD-2486
25.3 kDa (predicted)
Fc receptor, IgG, low affinity III

CD16/FCGR3 Protein, Rhesus, Recombinant (His & Avi), Biotinylated
RHC-CD-2376
25.3 kDa (predicted)
Fc receptor, IgG, low affinity III

CD16/FCGR3 Protein, Rhesus, Recombinant (His)
RHC-CD-2013
22.7 kDa (predicted)
Fc receptor, IgG, low affinity III

CD160 Monoclonal Antibody (CNX46-3), Biotin-Conjugate
BR00000778

CD160 Monoclonal Antibody (eBioCNX46-3 (CNX46-3)), Biotin-Conjugate
BR00000670

CD160 Protein, Human, Recombinant (hFc)
RHC-CD-1579
50-60 kDa (reducing condition)
Natural Killer Cell Receptor BY55, CD160 Antigen, CD160, BY55

CD160 Protein, Human, Recombinant (His & Avi)
RHC-CD-1763
17.7 kDa (predicted). Due to glycosylation, the pr
NK28, NK1, CD160, BY55FLJ46513, BY55

CD160 Protein, Human, Recombinant (His)
RHC-CD-1727
16.4 kDa (predicted); 25 kDa (reducing condition,
NK28, NK1, CD160 molecule, BY55

CD160 Protein, Mouse, Recombinant (hFc)
RHC-CD-1691
41.9 kDa (predicted)
CD160 molecule, By55, AU045688

CD160 Protein, Mouse, Recombinant (His)
RHC-CD-1670
20-25 kDa (reducing condition)
CD160 antigen, Cd160

CD160 Protein, Rhesus macaque, Recombinant (hFc)
RHC-CD-1743
55-65 kDa (reducing condition)
CD160 antigen, Cd160

CD160 Protein, Rhesus macaque, Recombinant (His)
RHC-CD-1378
16-30 kDa (reducing condition)
CD160 antigen, Cd160

CD160 Protein, Rhesus, Recombinant
RHC-CD-1390
15.6 kDa (predicted)
CD160 molecule

CD160 Protein, Rhesus, Recombinant (hFc)
RHC-CD-1608
41.8 kDa (predicted)
CD160 molecule

CD160 Protein, Rhesus, Recombinant (His)
RHC-CD-1342
16.3 kDa (predicted)
CD160 molecule

CD160/BY55 HUMAN
IAR42413183

CD161 Protein, Cynomolgus, Recombinant (His & Avi)
RHC-CD-0746
21.5 kDa (predicted). Due to glycosylation, the pr
NKRP1ANKR, NKR-P1A, NKRP1A, NKR-P1, NKRP1, NKR, Ly59, KLRB1, HNKR-P1a, CLEC5B, CD161

CD161 Protein, Cynomolgus, Recombinant (His & Avi), Biotinylated
RHC-CD-0588
21.5 kDa (predicted). Due to glycosylation, the pr
NKRP1ANKR, NKR-P1A, NKRP1A, NKR-P1, NKRP1, NKR, Ly59, KLRB1, HNKR-P1a, CLEC5B, CD161

CD161 Protein, Human, Recombinant (C-hFc)
RHC-CD-0495
55-70 kDa (reducing condition)
NKR-P1A, NKRP1A, Natural killer cell surface protein P1A, KLRB1, Killer cell lectin-like receptor subfamily B member 1, HNKR-P1a, C-type lectin domain family 5 member B, CLEC5B, CD161

CD161 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-0538
21.4 kDa (predicted). Due to glycosylation, the pr
NKRP1ANKR, NKR-P1A, NKRP1A, NKR-P1, NKRP1, NKR, Ly59, KLRB1, HNKR-P1a, CLEC5B, CD161

CD161 Protein, Human, Recombinant (His)
RHC-CD-0383
19.6 kDa (predicted). Due to glycosylation, the pr
NKRP1ANKR, NKR-P1A, NKRP1A, NKR-P1, NKRP1, NKR, Ly59, KLRB1, HNKR-P1a, CLEC5B, CD161

CD161 Protein, Human, Recombinant (N-hFc)
RHC-CD-0482
55-70 kDa (reducing condition)
NKR-P1A, NKRP1A, Natural killer cell surface protein P1A, KLRB1, Killer cell lectin-like receptor subfamily B member 1, HNKR-P1a, C-type lectin domain family 5 member B, CLEC5B, CD161

CD163 Monoclonal Antibody (eBioGHI/61 (GHI/61)), Biotin-Conjugate
BR00000181

CD163 Monoclonal Antibody (GHI/61), Biotin-Conjugate
BR00001168

CD163 Polyclonal Antibody, Biotin-Conjugate
BR00001304

CD163 Protein, Human, Recombinant (His & Avi)
RHC-CD-1801
111.4 kDa (predicted). Due to glycosylation, the p
sCD163, SCARI1, RM3/1, MM130, M130, HbSR, GHI/61, CD163 molecule, CD163

CD163 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-2224
111.4 kDa (predicted). Due to glycosylation, the p
sCD163, SCARI1, RM3/1, MM130, M130, HbSR, GHI/61, CD163 molecule, CD163

CD163 Protein, Mouse, Recombinant (His)
RHC-CD-2326
109.53 kDa (predicted). Due to glycosylation, the
sCD163, SCARI1, RM3/1, MM130, M130, HbSR, GHI/61, CD163 molecule, CD163

CD164 HUMAN
IAR42413144

CD164 Protein, Cynomolgus, Recombinant (hFc)
RHC-CD-3016
41.6 kDa (predicted)
CD164 molecule, sialomucin

CD164 Protein, Human, Recombinant (hFc)
RHC-CD-2884
41.2 kDa (predicted). Due to glycosylation, the pr
sialomucin, MUC-24, MGC-24v, MGC-24, Endolyn, Cd164

CD164 Protein, Human, Recombinant (His)
RHC-CD-3049
15.9 kDa (predicted); 40-110 kDa (reducing conditi
MUC-24, MGC-24, endolyn, CD164 molecule, sialomucin

CD164 Protein, Mouse, Recombinant (hFc)
RHC-CD-2994
41.4 kDa (predicted). Due to glycosylation, the pr
sialomucin, MUC-24, MGC-24v, MGC-24, Endolyn, Cd164

CD164 Protein, Rat, Recombinant (hFc)
RHC-CD-2936
41.3 kDa (predicted); 90 and 35 kDa (reducing cond
CD164 molecule, sialomucin

CD166/ALCAM HUMAN
IAR42413199

CD166/ALCAM Protein, Cynomolgus, Recombinant (hFc)
RHC-CD-2899
82.9 kDa (predicted)
activated leukocyte cell adhesion molecule

CD166/ALCAM Protein, Cynomolgus, Recombinant (His)
RHC-CD-2926
57.3 kDa (predicted); 65-68 kDa (reducing conditio
activated leukocyte cell adhesion molecule

CD166/ALCAM Protein, Human, Recombinant (hFc)
RHC-CD-2970
82.7 kDa (predicted)
MEMD, CD166, activated leukocyte cell adhesion molecule

CD166/ALCAM Protein, Human, Recombinant (His)
RHC-CD-2980
57.4 kDa (predicted); 78.3 kDa (reducing condition
MEMD, CD166, activated leukocyte cell adhesion molecule

CD166/ALCAM Protein, Mouse, Recombinant (His & hFc)
RHC-CD-2910
84.2 kDa (predicted); 105-110 kDa&210 kDa (reducin
SC1, MuSC, DM-GRASP, CD166, BEN, AI853494, activated leukocyte cell adhesion molecule

CD166/ALCAM Protein, Mouse, Recombinant (His)
RHC-CD-2889
57.7 kDa (predicted); 70-80 kDa (reducing conditio
SC1, MuSC, DM-GRASP, CD166, BEN, AI853494, activated leukocyte cell adhesion molecule

CD166/ALCAM Protein, Rat, Recombinant (hFc)
RHC-CD-3045
83.1 kDa (predicted); 94 kDa (reducing condition,
activated leukocyte cell adhesion molecule

CD166/ALCAM Protein, Rat, Recombinant (His)
RHC-CD-2943
57.5 kDa (predicted); 68-91 kDa (reducing conditio
activated leukocyte cell adhesion molecule

CD16a (F176) Protein, Human, Recombinant (His & Avi)
RHC-RP-1974
24.7 kDa (predicted). Due to glycosylation, the pr
IMD20, IGFR3, FcRIIIa, FcRIII, FcR-10, FcgRIIIA, FCGRIII, FCGR3A, FCGR3, FCG3, Fc +¦ RIIIA/CD16a (F176), Fc +¦ RIIIA, Fc gamma RIIIA, CD16A, CD16

CD16a (V176) Domain 2 Protein, Human, Recombinant (mFc)
RHC-RP-1890
35.29 kDa (predicted). Due to glycosylation, the p
IMD20, IGFR3, FcRIIIa, FcRIII, FcR-10, FcgRIIIA, FCGRIII, FCGR3A, FCGR3, FCG3, Fc +¦ RIIIA/CD16a (V176) Domain 2 Protein, Fc +¦ RIIIA, Fc gamma RIIIA, CD16A, CD16

CD16a (V176) Protein, Human, Recombinant (His & Avi)
RHC-RP-1999
24.7 kDa (predicted). Due to glycosylation, the pr
IMD20, IGFR3, FcRIIIa, FcRIII, FcR-10, FcgRIIIA, FCGRIII, FCGR3A, FCGR3, FCG3, Fc +¦ RIIIA/CD16a (V176), Fc +¦ RIIIA, Fc gamma RIIIA, CD16A, CD16

CD16a Protein, Cynomolgus, Recombinant (His)
RHC-CD-2046
23.1 kDa (predicted)
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)

CD16a Protein, Cynomolgus, Recombinant (His), Biotinylated
RHC-CD-2041
23.1 kDa (predicted)
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)

CD16a Protein, Human, Recombinant (176 Phe, His & Avi)
RHC-CD-2250
25.1 kDa (predicted); 46 kDa (reducing condition,
IMD20, IGFR3, FCRIIIA, FCRIII, FCR-10, FCGRIII, FCGR3, FCG3, Fc +¦RIIIa, Fc gammaRIIIa, Fc fragment of IgG, low affinity IIIa, receptor (CD16a), CD16A, CD16

CD16a Protein, Human, Recombinant (176 Phe, His)
RHC-CD-2121
23.3 kDa (predicted)
IMD20, IGFR3, FCRIIIA, FCRIII, FCR-10, FCGRIII, FCGR3, FCG3, Fc +¦RIIIa, Fc gammaRIIIa, Fc fragment of IgG, low affinity IIIa, receptor (CD16a), CD16A, CD16

CD16a Protein, Human, Recombinant (176 Val, His & Avi)
RHC-CD-2485
25.6 kDa (predicted); 46 kDa (reducing condition,
IMD20, IGFR3, FCRIIIA, FCRIII, FCR-10, FCGRIII, FCGR3, FCG3, Fc +¦RIIIa, Fc gammaRIIIa, Fc fragment of IgG, low affinity IIIa, receptor (CD16a), CD16A, CD16

CD16a Protein, Human, Recombinant (176F, His & Avi), biotinylated
RHC-CD-2496
25.1 kDa (predicted); 48 kDa (reducing condition,
IMD20, IGFR3, FCRIIIA, FCRIII, FCR-10, FCGRIII, FCGR3, FCG3, Fc +¦RIIIa, Fc gammaRIIIa, Fc fragment of IgG, low affinity IIIa, receptor (CD16a), CD16A, CD16

CD16a Protein, Human, Recombinant (176F, His)
RHC-CD-1986
23.3 kDa (predicted); 45.2 kDa (reducing condition
IMD20, IGFR3, FCRIIIA, FCRIII, FCR-10, FCGRIII, FCGR3, FCG3, Fc +¦RIIIa, Fc gammaRIIIa, Fc fragment of IgG, low affinity IIIa, receptor (CD16a), CD16A, CD16

CD16a Protein, Human, Recombinant (F176V, His & Avi), Biotinylated
RHC-CD-2495
25.6 kDa (predicted); 48 kDa (reducing condition,
IMD20, IGFR3, FCRIIIA, FCRIII, FCR-10, FCGRIII, FCGR3, FCG3, Fc +¦RIIIa, Fc gammaRIIIa, Fc fragment of IgG, low affinity IIIa, receptor (CD16a), CD16A, CD16

CD16a Protein, Human, Recombinant (F176V, His)
RHC-CD-1800
23.3 kDa (predicted); 44.2 kDa (reducing condition
IMD20, IGFR3, FCRIIIA, FCRIII, FCR-10, FCGRIII, FCGR3, FCG3, Fc +¦RIIIa, Fc gammaRIIIa, Fc fragment of IgG, low affinity IIIa, receptor (CD16a), CD16A, CD16

CD16a Protein, Rat, Recombinant (His)
RHC-CD-1834
21.7 kDa (predicted); 28-33 kDa (reducing conditio
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)

CD16b Protein, Human, Recombinant (hFc & His)
RHC-CD-1912
70 kDa (reducing condition)
Low affinity immunoglobulin +¦ Fc region receptor III-B, Low affinity immunoglobulin gamma Fc region receptor III-B, IgG Fc receptor III-1, Fc-+¦ RIII-beta, FcR-10, FCGR3B, FCGR3, Fc-gamma RIII-+¦, Fc-gamma RIII-beta, FCG3, CD16b

CD16b Protein, Human, Recombinant (NA1, His & Avi), Biotinylated
RHC-CD-2385
23.75 kDa (predicted); 44.02 kDa (reducing conditi
FCRIIIb, FCRIII, FCR-10, FCGR3, FCG3, Fc +¦RIIIb, Fc gammaRIIIb, Fc fragment of IgG receptor IIIb, CD16b, CD16

CD16b Protein, Human, Recombinant (NA1s, His)
RHC-CD-2304
22.4 kDa (predicted); 35-45 kDa (reducing conditio
FCRIIIb, FCRIII, FCR-10, FCGR3, FCG3, Fc +¦RIIIb, Fc gammaRIIIb, Fc fragment of IgG receptor IIIb, CD16b, CD16

CD16b Protein, Human, Recombinant (NA2), Biotinylated
RHC-CD-1860
20 kDa (predicted)
FCRIIIb, FCRIII, FCR-10, FCGR3, FCG3, Fc +¦RIIIb, Fc gammaRIIIb, Fc fragment of IgG receptor IIIb, CD16b, CD16

CD16b Protein, Human, Recombinant (NA2, CHO, His)
RHC-CD-2150
22.2 kDa (predicted); 38-43 kDa (reducing conditio
FCRIIIb, FCRIII, FCR-10, FCGR3, FCG3, Fc +¦RIIIb, Fc gammaRIIIb, Fc fragment of IgG receptor IIIb, CD16b, CD16

CD16b Protein, Human, Recombinant (NA2, HEK293, His)
RHC-CD-2400
22.2 kDa (predicted); 46 kDa (reducing condition,
FCRIIIb, FCRIII, FCR-10, FCGR3, FCG3, Fc +¦RIIIb, Fc gammaRIIIb, Fc fragment of IgG receptor IIIb, CD16b, CD16

CD16b Protein, Human, Recombinant (NA2,His & Avi)
RHC-CD-1861
24.1 kDa (predicted)
FCRIIIb, FCRIII, FCR-10, FCGR3, FCG3, Fc +¦RIIIb, Fc gammaRIIIb, Fc fragment of IgG receptor IIIb, CD16b, CD16

CD16b Protein, Human, Recombinant (NA2,His & Avi), Biotinylated
RHC-CD-2275
24.1 kDa (predicted); 40-50 kDa (reducing conditio
FCRIIIb, FCRIII, FCR-10, FCGR3, FCG3, Fc +¦RIIIb, Fc gammaRIIIb, Fc fragment of IgG receptor IIIb, CD16b, CD16

CD16b Protein, Human, Recombinant (SH, His)
RHC-CD-2235
22.3 kDa (predicted)
FCRIIIb, FCRIII, FCR-10, FCGR3, FCG3, Fc +¦RIIIb, Fc gammaRIIIb, Fc fragment of IgG receptor IIIb, CD16b, CD16

CD171 Monoclonal Antibody (eBio5G3 (5G3)), Biotin-Conjugate
BR00000039

CD172a (SIRP alpha) Monoclonal Antibody (P84), Biotin-Conjugate
BR00000283

CD177 Protein, Human, Recombinant (GST & His)
RHC-CD-1570
63.6 kDa (predicted)
PRV-1, PRV1, Polycythemia rubra vera protein 1, NB1 GP, NB1 glycoprotein, NB1, Human neutrophil alloantigen 2a, HNA-2a, CD177 antigen, CD177

CD177 Protein, Human, Recombinant (His)
RHC-CD-1480
55 kDa (reducing condition)
PRV-1, PRV1, Polycythemia rubra vera protein 1, NB1 GP, NB1 glycoprotein, NB1, Human neutrophil alloantigen 2a, HNA-2a, CD177 antigen, CD177

CD178 (Fas Ligand) Monoclonal Antibody (MFL3), Biotin-Conjugate
BR00000476

CD178 (soluble) Polyclonal Antibody, Biotin-Conjugate
BR00000628

CD18 (LFA-1 beta) Monoclonal Antibody (M18/2), Biotin-Conjugate
BR00000613

CD18 (LFA-1 beta) Monoclonal Antibody (R3.3), Biotin-Conjugate
BR00000268

CD18 Monoclonal Antibody (3EB), Biotin-Conjugate
BR00001128

CD18 Monoclonal Antibody (MEM-48), Biotin-Conjugate
BR00000825

CD180 Monoclonal Antibody (MHR73), Biotin-Conjugate
BR00001132

CD183 (CXCR3) Monoclonal Antibody (CEW33D), Biotin-Conjugate
BR00000798

CD183 (CXCR3) Monoclonal Antibody (CXCR3-173), Biotin-Conjugate
BR00000217

CD184 (CXCR4) Monoclonal Antibody (12G5), Biotin-Conjugate
BR00000460

CD184 (CXCR4) Monoclonal Antibody (2B11), Biotin-Conjugate
BR00000195

CD185 (CXCR5) Monoclonal Antibody (MU5UBEE), Biotin-Conjugate
BR00000228

CD185 (CXCR5) Monoclonal Antibody (SPRCL5), Biotin-Conjugate
BR00000046

CD19 Car circRNA-LNP
BM-DEL-103

CD19 car mRNA (Mouse)-LNP
BM-DEL-088

CD19 Monoclonal Antibody (6OMP31), Biotin-Conjugate
BR00000264

CD19 Monoclonal Antibody (eBio1D3 (1D3)), Biotin-Conjugate
BR00000120

CD19 Monoclonal Antibody (HIB19), Biotin-Conjugate
BR00000167

CD19 Monoclonal Antibody (LT19), Biotin-Conjugate
BR00000276

CD19 Monoclonal Antibody (MB19-1), Biotin-Conjugate
BR00000286

CD19 Monoclonal Antibody (OTI2B11), Biotin-Conjugate
BR00001727

CD19 Monoclonal Antibody (OTI2D3), Biotin-Conjugate
BR00001427

CD19 Monoclonal Antibody (OTI2F6), Biotin-Conjugate
BR00001560

CD19 Monoclonal Antibody (OTI2G7), Biotin-Conjugate
BR00001561

CD19 Monoclonal Antibody (OTI3G7), Biotin-Conjugate
BR00001729

CD19 Monoclonal Antibody (SJ25C1), Biotin-Conjugate
BR00000088

CD19 Polyclonal Antibody, Biotin-Conjugate
BR00001499

CD19 Protein, Cynomolgus, Rhesus, Recombinant (hFc)
RHC-CART-0399
57 kDa (predicted)
CD19 molecule

CD19 Protein, Cynomolgus, Rhesus, Recombinant (His)
RHC-CART-0401
31.4 kDa (predicted)
CD19 molecule

CD19 Protein, Cynomolgus/Rhesus macaque, Recombinant (His)
RHC-CART-0372
30.96 kDa (predicted). Due to glycosylation, the p
MGC12802, Leu-12, CVID3, CD19, B4

CD19 Protein, Cynomolgus/Rhesus, Recombinant (His), Biotinylated
RHC-CART-0402
31.4 kDa (predicted)
CD19 molecule

CD19 Protein, Human, Recombinant (hFc & Avi), Biotinylated
RHC-CART-0281
58.65 kDa (predicted); 68.8 kDa and 48.1 kDa (redu
CVID3, CD19 molecule, B4

CD19 Protein, Human, Recombinant (hFc)
RHC-CART-0326
56.8 kDa (predicted)
CVID3, CD19 molecule, B4

CD19 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CART-0305
33.37 kDa (predicted); 56.84 kDa (reducing conditi
CVID3, CD19 molecule, B4

CD19 Protein, Human, Recombinant (His)
RHC-CART-0392
31.6 kDa (predicted); 47 kDa (reducing condition,
CVID3, CD19 molecule, B4

CD19 Protein, Human, Recombinant (His), Biotinylated
RHC-CART-0246
31.6 kDa (predicted)
CVID3, CD19 molecule, B4

CD19 Protein, Mouse, Recombinant (His)
RHC-CART-0378
31.1 kDa (predicted); 51.8 kDa (reducing condition
CD19 molecule, AW495831

CD19 Protein, Mouse, Recombinant (His), Biotinylated
RHC-CART-0238
31 kDa (predicted)
CD19 molecule, AW495831

CD19 Protein, Rat, Recombinant (His)
RHC-CD-0327
31.11 kDa (predicted); 52.24 kDa (reducing conditi
CD19 molecule

CD19 Protein, Rhesus macaque, Recombinant (hFc)
RHC-CART-0265
80-110 kDa (reducing condition)
T-Cell Surface Antigen Leu-12, Differentiation Antigen CD19, CD19, B-Lymphocyte Surface Antigen B4, B-Lymphocyte Antigen CD19

CD197 (CCR7) Monoclonal Antibody (3D12), Biotin-Conjugate
BR00000488

CD197 (CCR7) Monoclonal Antibody (4B12), Biotin-Conjugate
BR00000197

CD1A & B2M Heterodimer Protein, Rhesus, Recombinant (His)
RHC-CD-1098
45.2 kDa (predicted)
CD1A & B2M

CD1a Polyclonal Antibody, Biotin-Conjugate
BR00002632

CD1A Protein, Human, Recombinant (His)
RHC-CD-1024
33.3 kDa (predicted). Due to glycosylation, the pr
T6, R4, HTA1, FCB6, CD1a, CD1

CD1B & B2M Heterodimer Protein, Human, Recombinant (His)
RHC-CD-0907
44.7 kDa (predicted); 39.6&13.1 kDa (reducing cond
CD1B & B2M Heterodimer

CD1B & B2M Heterodimer Protein, Rhesus, Recombinant (His)
RHC-CD-1276
44.6 kDa (predicted)
CD1B & B2M

CD1B Protein, Human, Recombinant (hFc)
RHC-CD-0887
58.6 kDa (predicted); 59-69 kDa (reducing conditio
R1, CD1b molecule, CD1B, CD1A, CD1

CD1C & B2M Heterodimer Protein, Rhesus, Recombinant (His)
RHC-CD-1137
44.7 kDa (predicted)
CD1C & B2M

CD1C Monoclonal Antibody (OTI1F4), Biotin-Conjugate
BR00001569

CD1C Monoclonal Antibody (OTI2B3), Biotin-Conjugate
BR00001573

CD1C Monoclonal Antibody (OTI2D4), Biotin-Conjugate
BR00001572

CD1C Monoclonal Antibody (OTI2F1), Biotin-Conjugate
BR00001574

CD1C Monoclonal Antibody (OTI2F4), Biotin-Conjugate
BR00001317

CD1C Monoclonal Antibody (OTI4C7), Biotin-Conjugate
BR00001577

CD1C Monoclonal Antibody (OTI5A8), Biotin-Conjugate
BR00001378

CD1C Protein, Human, Recombinant (His)
RHC-CD-1223
36.2 kDa (predicted)
T-cell surface glycoprotein CD1c, CD1C

CD1D & B2M Heterodimer Protein, Human, Recombinant (His)
RHC-CD-0886
45 kDa (predicted); 43.2 and 12.5 kDa (reducing co
CD1D & B2M Heterodimer

CD1d Monoclonal Antibody (1B1), Biotin-Conjugate
BR00000607

CD1D Protein, Mouse, Recombinant (His & hFc)
RHC-CD-0922
60.4 kDa (predicted)
Ly-38, CD1d molecule, Cd1d, Cd1a, CD1.1, AI747460

CD1D Protein, Mouse, Recombinant (His)
RHC-CD-0916
33.7 kDa (predicted); 45-50 kDa (reducing conditio
Ly-38, CD1d molecule, Cd1d, Cd1a, CD1.1, AI747460

CD1D2 & B2M Heterodimer Protein, Mouse, Recombinant (His)
RHC-CD-1060
45.4 kDa (predicted)
CD1D2 & B2M

CD1E & B2M Heterodimer Protein, Cynomolgus, Recombinant (His)
RHC-CD-1097
44.5 kDa (predicted); 37.8&13.6 kDa (reducing cond
CD1E & B2M Heterodimer

CD1E HUMAN
IAR42413150

CD2 HUMAN
IAR4248410

CD2 Monoclonal Antibody (MEM-65), Biotin-Conjugate
BR00000823

CD2 Monoclonal Antibody (OTI1C5), Biotin-Conjugate
BR00001566

CD2 Monoclonal Antibody (OTI3E11), Biotin-Conjugate
BR00001567

CD2 Monoclonal Antibody (OX-34), Biotin-Conjugate
BR00000859

CD2 Monoclonal Antibody (RM2-5), Biotin-Conjugate
BR00000339

CD2 Monoclonal Antibody (RPA-2.10), Biotin-Conjugate
BR00000305

CD2 Monoclonal Antibody (T6.3), Biotin-Conjugate
BR00001125

CD2 Polyclonal Antibody, Biotin-Conjugate
BR00001321

CD2 Protein, Canine, Recombinant (hFc)
RHC-CD-2976
47.6 kDa (predicted); 64.4 kDa (reducing condition
CD2 molecule

CD2 Protein, Canine, Recombinant (His)
RHC-CD-3018
22.4 kDa (predicted); 40.7 kDa (reducing condition
CD2 molecule

CD2 Protein, Cynomolgus, Recombinant (aa 25-209, His)
RHC-CD-2922
22.49 kDa (predicted). Due to glycosylation, the p
T11, SRBC, LFA-3 receptor, LFA-2, CD2

CD2 Protein, Cynomolgus, Recombinant (hFc)
RHC-CD-2872
48.1 kDa (predicted); 63 kDa (reducing conditions)
CD2 molecule

CD2 Protein, Cynomolgus, Recombinant (His)
RHC-CD-3043
22.8 kDa (predicted); 35.7 kDa (reducing condition
CD2 molecule

CD2 Protein, Human, Recombinant (hFc)
RHC-CD-3038
48 kDa (predicted)
T11, SRBC, LFA-2, CD2 molecule

CD2 Protein, Human, Recombinant (His)
RHC-CD-2965
22.7 kDa (predicted); 37 kDa (reducing condition,
T11, SRBC, LFA-2, CD2 molecule

CD2 Protein, Mouse, Recombinant (His)
RHC-CD-2925
22 kDa (predicted); 35-45 kDa (reducing condition,
Ly-37, Ly37, LFA-2, CD2 molecule

CD2 Protein, Rat, Recombinant (hFc)
RHC-CD-2896
47.5 kDa (predicted); 58-64 kDa (reducing conditio
CD2 molecule

CD20 (MS4A1) Monoclonal Antibody (OTI10A5), Biotin-Conjugate
BR00001811

CD20 (MS4A1) Monoclonal Antibody (OTI11F7), Biotin-Conjugate
BR00001809

CD20 (MS4A1) Monoclonal Antibody (OTI1C12), Biotin-Conjugate
BR00001628

CD20 (MS4A1) Monoclonal Antibody (OTI2D3), Biotin-Conjugate
BR00001807

CD20 (MS4A1) Monoclonal Antibody (OTI3C4), Biotin-Conjugate
BR00001812

CD20 (MS4A1) Monoclonal Antibody (OTI4A4), Biotin-Conjugate
BR00001810

CD20 Monoclonal Antibody (2H7), Biotin-Conjugate
BR00000204

CD20 Monoclonal Antibody (LT20), Biotin-Conjugate
BR00000840

CD20 Polyclonal Antibody, Biotin-Conjugate
BR00000998

CD20 Protein, Canine, Recombinant (His & Myc)
RHC-CART-0367
17.4 kDa (predicted)
MS4A1, Membrane-spanning 4-domains subfamily A member 1, CD20, B-lymphocyte antigen CD20

CD20 Protein, Cynomolgus, Recombinant (aa 213-297, His)
RHC-CD-0267
11.2 kDa (predicted); 24-27 and 18 kDa (reducing c
membrane-spanning 4-domains, subfamily A, member 1

CD20 Protein, Ferret, Recombinant (His)
RHC-CART-0262
11.3 kDa (predicted); 25 kDa (reducing condition,
membrane-spanning 4-domains, subfamily A, member 1

CD20 Protein, Human, Recombinant (aa 213-297, His)
RHC-CART-0308
12.1 kDa (predicted); 23 kDa (reducing condition,
S7, MS4A2, MS4A1, membrane-spanning 4-domains, subfamily A, member 1, LEU-16, CVID5, CD20, Bp35, B1

CD20 Protein, Human, Recombinant (Flag)
RHC-CART-0296
33-37 kDa (reducing condition)
MS4A1, Membrane-spanning 4-domains subfamily A member 1, Leukocyte surface antigen Leu-16, CD20, Bp35, B-lymphocyte surface antigen B1, B-lymphocyte antigen CD20

CD20 Protein, Human, Recombinant (His & Avi)
RHC-CART-0413
16.8 kDa (predicted) same as Tris-Bis PAGE result.
S7, MS4A2, MS4A-1, MS4A1, Ly-44, LEU-16, CVID5, CD20S7, CD20 receptor, CD20, Bp35, B1

CD20 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CART-0291
16.8 kDa (predicted) same as Tris-Bis PAGE result.
MS4A-1, MS4A1, Membrane-spanning 4-domains subfamily A member 11, Leukocyte surface antigen Leu-16, CD20, Bp35, B-lymphocyte surface antigen B1

CD20 Protein, Human, Recombinant (His & Flag)
RHC-CART-0414
34-40 kDa (reducing condition)
MS4A1, Membrane-spanning 4-domains subfamily A member 1, Leukocyte surface antigen Leu-16, CD20, Bp35, B-lymphocyte surface antigen B1, B-lymphocyte antigen CD20

CD20 Protein, Human, Recombinant (TrxA)
RHC-CART-0332
23.9 kDa (predicted); 28.2 kDa (reducing condition
S7, MS4A2, MS4A1, membrane-spanning 4-domains, subfamily A, member 1, LEU-16, CVID5, CD20, Bp35, B1

CD20 Protein, Human, Recombinant (TrxA), Biotinylated
RHC-CART-0325
23.9 kDa (predicted)
S7, MS4A2, MS4A1, membrane-spanning 4-domains, subfamily A, member 1, LEU-16, CVID5, CD20, Bp35, B1

CD20 Protein, Mouse, Recombinant (His)
RHC-CART-0385
22.3 kDa (predicted)
MS4A1, Membrane-spanning 4-domains subfamily A member 1, CD20, B-lymphocyte antigen CD20

CD20 Protein-VLP, Canine, Recombinant (His)
RHC-CART-0275
34.4 kDa (predicted)
MS4A1, Membrane-spanning 4-domains subfamily A member 1, CD20, B-lymphocyte antigen CD20

CD200 HUMAN
IAR42413151

CD200 Monoclonal Antibody (OX-2), Biotin-Conjugate
BR00000868

CD200 Monoclonal Antibody (OX104), Biotin-Conjugate
BR00000324

CD200 Monoclonal Antibody (OX90), Biotin-Conjugate
BR00000779

CD200 Protein, Cynomolgus, Recombinant (His)
RHC-CD-1926
23.66 kDa (predicted). Due to glycosylation, the p
OX-2, OX2, My033, MRC, MOX2, MOX1, CD200

CD200 Protein, Human, Recombinant (hFc)
RHC-CD-2161
49.2 kDa (predicted)
OX-2, OX2, MRC, MOX2, MOX1, Cd200 molecule

CD200 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-1957
25.71 kDa (predicted); 49.07 kDa (reducing conditi
OX-2, OX2, MRC, MOX2, MOX1, Cd200 molecule

CD200 Protein, Human, Recombinant (His & SUMO)
RHC-CD-2356
35.4 kDa (predicted)
OX-2 membrane glycoprotein, MOX2, MOX1, CD200

CD200 Protein, Human, Recombinant (His)
RHC-CD-2174
24 kDa (predicted); 40-45 kDa (reducing condition,
OX-2, OX2, MRC, MOX2, MOX1, Cd200 molecule

CD200 Protein, Mouse, Recombinant (aa 31-232, His)
RHC-CD-1919
23.6 kDa (predicted). Due to glycosylation, the pr
OX-2, OX2, My033, MRC, MOX2, MOX1, CD200

CD200 Protein, Mouse, Recombinant (His)
RHC-CD-2411
24 kDa (predicted)
OX2, Mox2, Cd200 molecule

CD200 Protein, Rhesus, Recombinant (hFc)
RHC-CD-2034
49.6 kDa (predicted)
Cd200 molecule

CD200 Protein, Rhesus, Recombinant (His)
RHC-CD-2318
24 kDa (predicted)
Cd200 molecule

CD200/OX-2 HUMAN
IAR42413181

CD200R (soluble) Monoclonal Antibody (OX110), Biotin-Conjugate
BR00001177

CD200R Protein, Cynomolgus, Recombinant (His)
RHC-ICP-0396
26 kDa (predicted)
CD200 receptor 1

CD200R Protein, Human, Recombinant (His & hFc)
RHC-ICP-0215
54.9 kDa (predicted); 90-100 kDa (reducing conditi
OX2R, MOX2R, HCRTR2, CD200R, CD200 receptor 1

CD200R Protein, Human, Recombinant (His)
RHC-ICP-0176
28.2 kDa (predicted); 50-60 kDa (reducing conditio
OX2R, MOX2R, HCRTR2, CD200R, CD200 receptor 1

CD200R Protein, Mouse, Recombinant (His & hFc)
RHC-RP-2924
51.3 kDa (predicted); 90-100 kDa (reducing conditi
OX2R, Mox2r, CD200R, CD200 receptor 1

CD200R Protein, Mouse, Recombinant (His)
RHC-ICP-0384
24.6 kDa (predicted); 55-65 kDa (reducing conditio
OX2R, Mox2r, CD200R, CD200 receptor 1

CD200R1/CRTR2 Protein, Cynomolgus, Recombinant (His)
RHC-ICP-0120
28.09 kDa (predicted). Due to glycosylation, the p
OX2R, MOX2R, MOX2 receptor, HCRTR2, CRTR2, CD200R, CD200 receptor 1, CD200 R1

CD200R1/CRTR2 Protein, Human, Recombinant (hFc)
RHC-ICP-0208
53.7 kDa (predicted). Due to glycosylation, the pr
OX2R, MOX2R, MOX2 receptor, HCRTR2, CRTR2, CD200R, CD200 receptor 1, CD200 R1

CD200R1/CRTR2 Protein, Human, Recombinant (His & Avi)
RHC-ICP-0051
29.7 kDa (predicted). Due to glycosylation, the pr
OX2R, MOX2R, MOX2 receptor, HCRTR2, CRTR2, CD200R, CD200 receptor 1, CD200 R1

CD200R1/CRTR2 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-ICP-0130
29.7 kDa (predicted). Due to glycosylation, the pr
OX2R, MOX2R, MOX2 receptor, HCRTR2, CRTR2, CD200R, CD200 receptor 1, CD200 R1

CD200R1/CRTR2 Protein, Human, Recombinant (His)
RHC-ICP-0242
50-80 kDa (reducing condition)
OX2R, MOX2R, CRTR2, Cell Surface Glycoprotein OX2 Receptor 1, Cell Surface Glycoprotein CD200 Receptor 1, CD200R1, CD200R, CD200 Cell Surface Glycoprotein Receptor

CD200R4 Protein, Mouse, Recombinant (hFc)
RHC-RP-2925
50.6 kDa (predicted); 80-90 kDa (reducing conditio
MCD200RLa, F630107N04Rik, Cd200r4, CD200 receptor 4

CD200R4 Protein, Mouse, Recombinant (His)
RHC-RP-2851
25 kDa (predicted); 50-60 kDa (reducing condition,
MCD200RLa, F630107N04Rik, Cd200r4, CD200 receptor 4

CD200RLa Protein, Cynomolgus, Recombinant (hFc)
RHC-RP-2582
51.3 kDa (predicted); 70-85 kDa (reducing conditio
CD200RLa, CD200 receptor 1 like

CD200RLa Protein, Human, Recombinant (His)
RHC-RP-2581
25.2 kDa (predicted); 45-60 kDa (reducing conditio
CD200RLa, CD200R2, CD200 receptor 1 like

CD201 (EPCR) Monoclonal Antibody (eBio1560 (1560)), Biotin-Conjugate
BR00000201

CD202b (TIE2) Monoclonal Antibody (TEK4), Biotin-Conjugate
BR00000166

CD204 Monoclonal Antibody (2F8), Biotin-Conjugate
BR00000844

CD204/MSR1 Protein, Human, Recombinant (His)
RHC-CD-3427
43 kDa (predicted); 55-65 kDa (reducing condition,
SR-A, SRA, SCARA1, phSR2, phSR1, macrophage scavenger receptor 1, CD204

CD204/MSR1 Protein, Mouse, Recombinant (His)
RHC-CD-3518
32 kDa (predicted)
SR-AII, SR-AI, Scvr, Scara1, MSR-A, MSR, MRS-A, macrophage scavenger receptor 1

CD204/MSR1 Protein, Rat, Recombinant (hFc)
RHC-CD-3386
69.2 kDa (predicted); 89 kDa (reducing conditions)
macrophage scavenger receptor 1

CD204/MSR1 Protein, Rat, Recombinant (His)
RHC-CD-3440
43.1 kDa (predicted); 51-60 kDa (reducing conditio
macrophage scavenger receptor 1

CD205 Monoclonal Antibody (205yekta), Biotin-Conjugate
BR00000441

CD205 Monoclonal Antibody (MG38), Biotin-Conjugate
BR00000341

CD206 Monoclonal Antibody (MR5D3), Biotin-Conjugate
BR00000622

CD207 (Langerin) Monoclonal Antibody (eBioL31), Biotin-Conjugate
BR00000297

CD209 (DC-SIGN) Monoclonal Antibody (eB-h209), Biotin-Conjugate
BR00000660

CD209/DC-SIGN Protein, Human, Recombinant (His)
RHC-CD-1571
40.5 kDa (predicted). Due to glycosylation, the pr
MGC129965, DC-SIGN1, DC-SIGN, CLEC4L, CDSIGN, CD209 molecule, CD209

CD209a Monoclonal Antibody (LWC06), Biotin-Conjugate
BR00000351

CD21 Monoclonal Antibody (21A/5), Biotin-Conjugate
BR00000706

CD21 Monoclonal Antibody (BB6-11C9.6), Biotin-Conjugate
BR00000934

CD21 Polyclonal Antibody, Biotin-Conjugate
BR00001305

CD21 Protein, Human, Recombinant (His)
RHC-CD-0105
105.3 kDa (predicted). Due to glycosylation, the p
SLEB9, EBV receptor, CVID7, CR2, CD21, C3DRSLEB9, C3DR

CD21 Protein, Mouse, Recombinant (His)
RHC-CD-0183
106.03 kDa (predicted). Due to glycosylation, the
SLEB9, EBV receptor, CVID7, CR2, CD21, C3DRSLEB9, C3DR

CD21/CD35 Monoclonal Antibody (eBio8D9 (8D9)), Biotin-Conjugate
BR00000058

CD22 (soluble) Polyclonal Antibody, Biotin-Conjugate
BR00000480

CD22 Monoclonal Antibody (2D6), Biotin-Conjugate
BR00000882

CD22 Monoclonal Antibody (MEM-01), Biotin-Conjugate
BR00000831

CD226 (DNAM-1) Monoclonal Antibody (DX11), Biotin-Conjugate
BR00000908

CD226 HUMAN
IAR42413152

CD226 Protein, Cynomolgus, Recombinant (His)
RHC-CD-0572
28 kDa (predicted); 45.7 kDa (reducing condition,
CD226 molecule

CD226 Protein, Rat, Recombinant (hFc)
RHC-CD-0705
53.6 kDa (predicted); 62-68 kDa (reducing conditio
CD226 molecule

CD226 Protein, Rat, Recombinant (His)
RHC-CD-0450
28 kDa (predicted)
CD226 molecule

CD228 Protein, Human, Recombinant (His)
RHC-CD-3343
76.60 kDa (predicted). Due to glycosylation, the p
MFI2, MELTF, Melanotransferrin, MAP97, CD228

CD229 Protein, Human, Recombinant (His & Avi)
RHC-CD-2056
47.7 kDa (predicted). Due to glycosylation, the pr
T100, SLAMF3, LY9, Lgp100, CD229, AI893573

CD229 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-2445
47.7 kDa (predicted). Due to glycosylation, the pr
T100, SLAMF3, LY9, Lgp100, CD229, AI893573

CD229 Protein, Mouse, Recombinant (His)
RHC-CD-1990
46.5 kDa (predicted); 65 kDa (reducing condition,
T100, SLAMF3, lymphocyte antigen 9, Ly-9, Lgp100, CD229, AI893573

CD23 (Fc Epsilon RII) Monoclonal Antibody (FCER2/3592), Biotin-Conjugate
BR00001400

CD23 HUMAN
IAR42413197

CD23 Monoclonal Antibody (B3B4), Biotin-Conjugate
BR00000463

CD23 Protein, Human, Recombinant (His)
RHC-CD-0277
33.2 kDa (predicted); 44 kDa (reducing condition,
MPCL, MGC40078, MCL, IGEBF, FCE2, Fc fragment of IgE receptor II, CLECSF8, CLEC-6, CLEC6, CLEC4J, CD23A, CD23, BLAST-2

CD23 Protein, Mouse, Recombinant (His)
RHC-CD-0278
34.3 kDa (predicted); 40-45 kDa (reducing conditio
Ly-42, Fcer2a, Fcer2, Fce2, Fc fragment of IgE receptor II, CD23

CD23 Protein, Rat, Recombinant (hFc)
RHC-CD-0134
77.7 kDa (predicted); 61 kDa (reducing condition,
Fcer2a, FCER2, Fc fragment of IgE receptor II

CD235a (Glycophorin A) Monoclonal Antibody (HIR2 (GA-R2)), Biotin-Conjugate
BR00000169

CD235a Monoclonal Antibody (JC159), Biotin-Conjugate
BR00000787

CD235a Monoclonal Antibody (YTH89.1), Biotin-Conjugate
BR00000875

CD24 (MOUSE): FC (HUMAN)
IAR42413209

CD24 Monoclonal Antibody (eBioSN3 (SN3 A5-2H10)), Biotin-Conjugate
BR00000171

CD24 Monoclonal Antibody (M1/69), Biotin-Conjugate
BR00000137

CD24 Monoclonal Antibody (SN3), Biotin-Conjugate
BR00000788

CD24 Monoclonal Antibody (YBM5.10.4), Biotin-Conjugate
BR00000895

CD24 Protein (Primary Amine Labeling), Cynomolgus, Recombinant (hFc), Biotinylated
RHC-CD-0302
30.2 kDa (predicted). Due to glycosylation, the pr
MGC75043, FLJ43543, FLJ22950, CD24A, CD24 molecule, CD 24

CD24 Protein (Primary Amine Labeling), Human, Recombinant (hFc), Biotinylated
RHC-CD-0154
29.9 kDa (predicted). Due to glycosylation, the pr
MGC75043, FLJ43543, FLJ22950, CD24A, CD24 molecule, CD 24

CD24 Protein (Primary Amine Labeling), Human, Recombinant (mFc), Biotinylated
RHC-CD-0036
29.5 kDa (predicted). Due to glycosylation, the pr
MGC75043, FLJ43543, FLJ22950, CD24A, CD24 molecule, CD 24

CD24 Protein, Cynomolgus, Recombinant (hFc)
RHC-CD-0099
30.2 kDa (predicted). Due to glycosylation, the pr
MGC75043, FLJ43543, FLJ22950, CD24A, CD24 molecule, CD 24

CD24 Protein, Human, Recombinant (GST)
RHC-CD-0244
31.6 kDa (predicted) same as Tris-Bis PAGE result.
MGC75043, FLJ43543, FLJ22950, CD24A, CD24 molecule, CD 24

CD24 Protein, Human, Recombinant (hFc & Avi), Biotinylated
RHC-CD-0333
31.66 kDa (predicted); 47.5 kDa (reducing conditio
MGC75043, FLJ43543, FLJ22950, CD24A, CD24 molecule

CD24 Protein, Human, Recombinant (hFc)
RHC-CD-0207
30 kDa (predicted); 47 kDa (reducing condition, du
MGC75043, FLJ43543, FLJ22950, CD24A, CD24 molecule

CD24 Protein, Human, Recombinant (His & Avi)
RHC-CD-0182
6.5 kDa (predicted). Due to glycosylation, the pro
MGC75043, FLJ43543, FLJ22950, CD24A, CD24 molecule, CD 24

CD24 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-0147
6.5 kDa (predicted). Due to glycosylation, the pro
MGC75043, FLJ43543, FLJ22950, CD24A, CD24 molecule, CD 24

CD24 Protein, Human, Recombinant (mFc)
RHC-CD-0094
29.5 kDa (predicted)
MGC75043, FLJ43543, FLJ22950, CD24A, CD24 molecule

CD24 Protein, Human, Recombinant (rFc)
RHC-CD-0259
28.3 kDa (predicted)
MGC75043, FLJ43543, FLJ22950, CD24A, CD24 molecule

CD24 Protein, Mouse, Recombinant (hFc)
RHC-CD-0030
29.7 kDa (predicted); 48-52 kDa (reducing conditio
Ly-52, Cd24a, CD24 molecule, CD24

CD24 Protein, Rat, Recombinant (hFc)
RHC-CD-0282
29.9 kDa (predicted); 43-48 kDa (reducing conditio
Cd24a, CD24 molecule, CD24

CD24 Protein-VLP, Cynomolgus, Recombinant
RHC-CD-0138
3.8 kDa (predicted)
MGC75043, FLJ43543, FLJ22950, CD24A, CD24 molecule, CD 24

CD24 Protein-VLP, Human, Recombinant
RHC-CD-0245
5.0 kDa (predicted)
MGC75043, FLJ43543, FLJ22950, CD24A, CD24 molecule, CD 24

CD244 HUMAN
IAR42413163

CD244 Monoclonal Antibody (eBioC1.7 (C1.7)), Biotin-Conjugate
BR00000338

CD244/2B4/SLAMF4 HUMAN
IAR42413172

CD247 HUMAN
IAR42413164

CD249 (BP-1) Monoclonal Antibody (6C3), Biotin-Conjugate
BR00000620

CD25 (soluble) Polyclonal Antibody, Biotin-Conjugate
BR00000536

CD25 Monoclonal Antibody (BC96), Biotin-Conjugate
BR00000165

CD25 Monoclonal Antibody (eBio7D4 (7D4)), Biotin-Conjugate
BR00000302

CD25 Monoclonal Antibody (MEM-140), Biotin-Conjugate
BR00000837

CD25 Monoclonal Antibody (MEM-181), Biotin-Conjugate
BR00000826

CD25 Monoclonal Antibody (MRC OX-39), Biotin-Conjugate
BR00000758

CD25 Monoclonal Antibody (OX-39), Biotin-Conjugate
BR00000860

CD25 Monoclonal Antibody (PC61.5), Biotin-Conjugate
BR00000019

CD25 Monoclonal Antibody (PC61.5.3), Biotin-Conjugate
BR00000668

CD25 Monoclonal Antibody (YTH906.9HL), Biotin-Conjugate
BR00000873

CD25/IL2R alpha Protein, Cynomolgus, Recombinant
RHC-CD-2535
22.4 kDa (predicted); 38-42 kDa (reducing conditio
interleukin 2 receptor, +¦, interleukin 2 receptor, alpha, CD25/IL2R +¦

CD25/IL2R alpha Protein, Cynomolgus, Recombinant (hFc)
RHC-CD-2814
48.7 kDa (predicted); 65 kDa (reducing conditions)
interleukin 2 receptor, +¦, interleukin 2 receptor, alpha, CD25/IL2R +¦

CD25/IL2R alpha Protein, Cynomolgus, Recombinant (His)
RHC-CD-2595
23.1 kDa (predicted); 43 kDa (reducing conditions)
interleukin 2 receptor, +¦, interleukin 2 receptor, alpha, CD25/IL2R +¦

CD25/IL2R alpha Protein, Human, Recombinant (hFc)
RHC-CD-2778
48.5 kDa (predicted); 72 kDa (reducing condition,
TCGFR, p55, interleukin 2 receptor, +¦, interleukin 2 receptor, alpha, IL-2RA, IL2R, IDDM10, CD25/IL2R +¦, CD25

CD25/IL2R alpha Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-2727
25 kDa (predicted)
TCGFR, p55, interleukin 2 receptor, +¦, interleukin 2 receptor, alpha, IL-2RA, IL2R, IDDM10, CD25/IL2R +¦, CD25

CD25/IL2R alpha Protein, Human, Recombinant (His)
RHC-CD-2559
23.3 kDa (predicted); 44 kDa (reducing condition,
TCGFR, p55, interleukin 2 receptor, +¦, interleukin 2 receptor, alpha, IL-2RA, IL2R, IDDM10, CD25/IL2R +¦, CD25

CD25/IL2R alpha Protein, Mouse, Recombinant (hFc)
RHC-CD-2540
51.4 kDa (predicted)
Ly-43, interleukin 2 receptor, +¦, interleukin 2 receptor, alpha, Il2r, CD25/IL2R +¦, CD25

CD25/IL2R alpha Protein, Mouse, Recombinant (His)
RHC-CD-2763
26 kDa (predicted); 50-55 kDa (reducing condition,
Ly-43, interleukin 2 receptor, +¦, interleukin 2 receptor, alpha, Il2r, CD25/IL2R +¦, CD25

CD25/IL2R alpha Protein, Rat, Recombinant (His)
RHC-CD-2809
25.9 kDa (predicted)
interleukin 2 receptor, +¦, interleukin 2 receptor, alpha, CD25/IL2R +¦

CD25/IL2R alpha Protein, Rhesus, Recombinant (His & Avi), Biotinylated
RHC-CD-2681
24.9 kDa (predicted)
interleukin 2 receptor, +¦, interleukin 2 receptor, alpha, CD25/IL2R +¦

CD253 (TRAIL) Monoclonal Antibody (N2B2), Biotin-Conjugate
BR00000648

CD254 (RANK Ligand) Monoclonal Antibody (IK22/5), Biotin-Conjugate
BR00000265

CD254 (RANK Ligand) Monoclonal Antibody (MIH24), Biotin-Conjugate
BR00000342

CD26 / Dipeptidyl Peptidase 4 Protein (Cynomolgus, HEK293)
NZs001689
Dipeptidyl peptidase 4; ADABP; ADCP-2; DPP IV; TP103; CD26; DPP4

CD26 Monoclonal Antibody (H207-1082), Biotin-Conjugate
BR00001180

CD26 Monoclonal Antibody (M-A261), Biotin-Conjugate
BR00000252

CD26 Monoclonal Antibody (OX-61), Biotin-Conjugate
BR00000865

CD261 (DR4) Monoclonal Antibody (DJR1), Biotin-Conjugate
BR00000606

CD262 (DR5) Monoclonal Antibody (DJR2-4 (7-8)), Biotin-Conjugate
BR00000087

CD262 (DR5) Monoclonal Antibody (MD5-1), Biotin-Conjugate
BR00000664

CD265 (RANK) Monoclonal Antibody (R12-31), Biotin-Conjugate
BR00000293

CD266 (TWEAK Receptor) Monoclonal Antibody (ITEM-4), Biotin-Conjugate
BR00000701

CD267 (TACI) Monoclonal Antibody (11H3), Biotin-Conjugate
BR00000336

CD267 (TACI) Polyclonal Antibody, Biotin-Conjugate
BR00000377

CD27 Ligand/CD70 Protein, Cynomolgus, Recombinant (His)
RHC-CART-0214
18.4 kDa (predicted). Due to glycosylation, the pr
TNFSF7G, TNFSF7, CD70 molecule, CD70, CD27LG, CD27-L, CD27 Ligand, Ki-24 antigen

CD27 Ligand/CD70 Trimer Protein (Primary Amine Labeling), Human, Recombinant (His), Biotinylated
RHC-CART-0029
51.8 kDa (predicted). Due to glycosylation, the pr
TNFSF7G, TNFSF7, CD70 molecule, CD70, CD27LG, CD27-L, CD27 Ligand, Ki-24 antigen

CD27 Ligand/CD70 Trimer Protein, Human, Recombinant (His)
RHC-CART-0212
51.8 kDa (predicted). Due to glycosylation, the pr
TNFSF7G, TNFSF7, CD70 molecule, CD70, CD27LG, CD27-L, CD27 Ligand, Ki-24 antigen

CD27 Ligand/CD70 Trimer Protein, Human, Recombinant (His), FITC-Labeled
RHC-CART-0131
51.8 kDa (predicted). Due to glycosylation, the pr
TNFSF7G, TNFSF7, CD70 molecule, CD70, CD27LG, CD27-L, CD27 Ligand, Ki-24 antigen

CD27 Monoclonal Antibody (LG.3A10), Biotin-Conjugate
BR00000896

CD27 Monoclonal Antibody (LG.7F9), Biotin-Conjugate
BR00000205

CD27 Monoclonal Antibody (O323), Biotin-Conjugate
BR00000462

CD27/TNFRSF7 Protein, Cynomolgus, Recombinant (His)
RHC-CD-0104
20.41 kDa (predicted). Due to glycosylation, the p
Tp55, TNFRSF7, T14, S152. LPFS2, S152, CD27 antigen

CD27/TNFRSF7 Protein, Human, Recombinant (hFc & Avi), Biotinylated
RHC-CD-0286
47.8 kDa (predicted)
Tp55, TNFRSF7, T14, S152.LPFS2, S152. LPFS2, S152, CD27 molecule

CD27/TNFRSF7 Protein, Human, Recombinant (hFc & His)
RHC-CD-0044
60 kDa (reducing condition)
Tumor necrosis factor receptor superfamily member 7, T-cell activation antigen CD27, T14 and TNFRSF7., CD27L receptor, CD27 antigen

CD27/TNFRSF7 Protein, Human, Recombinant (hFc)
RHC-CD-0221
46.1 kDa (predicted)
Tp55, TNFRSF7, T14, S152.LPFS2, S152. LPFS2, S152, CD27 molecule

CD27/TNFRSF7 Protein, Human, Recombinant (His)
RHC-CD-0085
20.77 kDa (predicted); 27 kDa (reducing condition,
Tp55, TNFRSF7, T14, S152.LPFS2, S152. LPFS2, S152, CD27 molecule

CD27/TNFRSF7 Protein, Human, Recombinant (His), Biotinylated
RHC-CD-0067
20.77 kDa (predicted)
Tp55, TNFRSF7, T14, S152.LPFS2, S152. LPFS2, S152, CD27 molecule

CD27/TNFRSF7 Protein, Human, Recombinant (rFc)
RHC-CD-0090
44.4 kDa (predicted); 63 kDa (reducing conditions)
Tp55, TNFRSF7, T14, S152.LPFS2, S152. LPFS2, S152, CD27 molecule

CD27/TNFRSF7 Protein, Mouse, Recombinant (His & hFc)
RHC-CD-0066
46.2 kDa (predicted); 60-65 kDa (reducing conditio
Tp55, Tnfrsf7, S152, CD27 molecule

CD27/TNFRSF7 Protein, Mouse, Recombinant (His)
RHC-CD-0041
19.6 kDa (predicted); 35 kDa (reducing condition,
Tp55, Tnfrsf7, S152, CD27 molecule

CD27/TNFRSF7 Protein, Mouse, Recombinant (mFc)
RHC-CD-0161
44.17 kDa (predicted)
Tp55, Tnfrsf7, S152, CD27 molecule

CD27/TNFRSF7 Protein, Rat, Recombinant (hFc)
RHC-CD-0164
45 kDa (predicted)
CD27 molecule

CD27/TNFRSF7 Protein, Rat, Recombinant (mFc)
RHC-CD-0225
44.1 kDa (predicted)
CD27 molecule

CD27/TNFRSF7 Protein, Rhesus macaque, Recombinant (hFc)
RHC-CD-0242
60-90 kDa (reducing condition)
Tumor Necrosis Factor Receptor Superfamily Member 7, TNFRSF7, T-Cell Activation Antigen CD27, T14, CD27L Receptor, CD27 Antigen, CD27

CD27/TNFRSF7 Protein, Rhesus macaque, Recombinant (His)
RHC-CD-0236
40 kDa (reducing condition)
Tumor Necrosis Factor Receptor Superfamily Member 7, TNFRSF7, T-Cell Activation Antigen CD27, T14, CD27L Receptor, CD27 Antigen, CD27

CD27/TNFRSF7 Protein, Rhesus, Recombinant (hFc)
RHC-CD-0174
46.3 kDa (predicted)
CD27 molecule

CD27:CD70[Biotinylated] Inhibitor Screening Assay Kit
BR00028177
S152, LPFS2, CD27LG, TNFSF7

CD270 (HVEM) Monoclonal Antibody (eBioHVEM-122), Biotin-Conjugate
BR00000700

CD270 HUMAN
IAR4248419

CD272 (BTLA) Monoclonal Antibody (6F7), Biotin-Conjugate
BR00000360

CD272 (BTLA) Monoclonal Antibody (8F4), Biotin-Conjugate
BR00000443

CD272 (BTLA) Monoclonal Antibody (MIH26), Biotin-Conjugate
BR00000361

CD273 (B7-DC) Monoclonal Antibody (MIH18), Biotin-Conjugate
BR00000484

CD273 (B7-DC) Monoclonal Antibody (TY25), Biotin-Conjugate
BR00000612

CD273 HUMAN
IAR42413169

CD274 (PD-L1, B7-H1) Monoclonal Antibody (1-111A), Biotin-Conjugate
BR00000346

CD274 (PD-L1, B7-H1) Monoclonal Antibody (MIH1), Biotin-Conjugate
BR00000119

CD274 (PD-L1, B7-H1) Monoclonal Antibody (MIH5), Biotin-Conjugate
BR00000132

CD274 FROM MOUSE
IAR42413153

CD274 HUMAN
IAR4248418

CD274 Polyclonal Antibody, Biotin-Conjugate
BR00002052

CD275 (B7-H2) Monoclonal Antibody (HK5.3), Biotin-Conjugate
BR00000300

CD275 (B7-H2) Monoclonal Antibody (MIH12), Biotin-Conjugate
BR00000489

CD276 (B7-H3) Monoclonal Antibody (M3.2D7), Biotin-Conjugate
BR00000619

CD276 HUMAN
IAR4248416

CD278 (ICOS) Monoclonal Antibody (7E.17G9), Biotin-Conjugate
BR00000487

CD278 (ICOS) Monoclonal Antibody (C398.4A), Biotin-Conjugate
BR00000609

CD278 (ICOS) Monoclonal Antibody (ISA-3), Biotin-Conjugate
BR00000211

CD279 (HUMAN): FC (HUMAN)
IAR42413213

CD279 (PD-1) Monoclonal Antibody (eBioJ105 (J105)), Biotin-Conjugate
BR00000038

CD279 (PD-1) Monoclonal Antibody (J43), Biotin-Conjugate
BR00000149

CD279 (PD-1) Monoclonal Antibody (RMP1-30), Biotin-Conjugate
BR00000473

CD28 Monoclonal Antibody (37.51), Biotin-Conjugate
BR00000194

CD28 Monoclonal Antibody (AV7), Biotin-Conjugate
BR00000750

CD28 Monoclonal Antibody (CD28.2), Biotin-Conjugate
BR00000170

CD28 Monoclonal Antibody (JJ319), Biotin-Conjugate
BR00000857

CD28 Protein, Canine, Recombinant (His)
RHC-CD-0054
16.7 kDa (predicted). Due to glycosylation, the pr
MGC138290, CD28 molecule, CD28 antigen (Tp44), CD28

CD28 Protein, Canine, Recombinant (mFc)
RHC-CD-0295
41.6 kDa (predicted). Due to glycosylation, the pr
MGC138290, CD28 molecule, CD28 antigen (Tp44), CD28

CD28 Protein, Cynomolgus, Recombinant (hFc)
RHC-CD-0140
41.9 kDa (predicted)
CD28 molecule

CD28 Protein, Human, Cynomolgus, Rhesus, Recombinant (His & Avi), Biotinylated
RHC-CD-0195
18.40 kDa (predicted); 41.73 kDa (reducing conditi
CD28 molecule

CD28 Protein, Human, Cynomolgus, Rhesus, Recombinant (His)
RHC-CD-0229
16.6 kDa (predicted)
CD28 molecule

CD28 Protein, Human, Cynomolgus, Rhesus, Recombinant (mFc)
RHC-CD-0205
41.52 kDa (predicted); 58.66 kDa (reducing conditi
CD28 molecule

CD28 Protein, Human, Recombinant (hFc & Avi), Biotinylated
RHC-CD-0068
43.7 kDa (predicted)
Tp44, CD28 molecule

CD28 Protein, Human, Recombinant (hFc)
RHC-CD-0213
42 kDa (predicted); 55-65 kDa (reducing condition,
Tp44, CD28 molecule

CD28 Protein, Human/Cynomolgus, Recombinant (hFc & Avi), Biotinylated
RHC-CD-0313
60-90 kDa (reducing condition)
TP44, T-cell-specific surface glycoprotein CD28, CD28 molecule, CD28 antigen, CD28

CD28 Protein, Human/Cynomolgus, Recombinant (His)
RHC-CD-0015
30-40 kDa (reducing condition)
TP44, T-cell-specific surface glycoprotein CD28, CD28 molecule, CD28 antigen, CD28

CD28 Protein, Human/Cynomolgus/Rhesus macaque, Recombinant (His & Avi)
RHC-CD-0103
18.2 kDa (predicted). Due to glycosylation, the pr
MGC138290, CD28 molecule, CD28 antigen (Tp44), CD28

CD28 Protein, Human/Cynomolgus/Rhesus macaque, Recombinant (His & Avi), Biotinylated
RHC-CD-0056
18.2 kDa (predicted). Due to glycosylation, the pr
MGC138290, CD28 molecule, CD28 antigen (Tp44), CD28

CD28 Protein, Mouse, Recombinant (hFc & His)
RHC-CD-0010
60 kDa (reducing condition)
T-cell-specific surface glycoprotein CD28, CD28

CD28 Protein, Mouse, Recombinant (hFc)
RHC-CD-0194
41.8 kDa (predicted)
CD28 molecule

CD28 Protein, Mouse, Recombinant (His)
RHC-CD-0217
16.5 kDa (predicted); 32-35 kDa (reducing conditio
CD28 molecule

CD28 Protein, Mouse, Recombinant (His), Biotinylated
RHC-CD-0326
16.5 kDa (predicted); 32-35 kDa (reducing conditio
CD28 molecule

CD28 Protein, Rat, Recombinant (hFc)
RHC-CD-0323
42 kDa (predicted)
CD28 molecule

CD28 Protein, Rat, Recombinant (His)
RHC-CD-0063
16.4 kDa (predicted)
CD28 molecule

CD28 Rabbit Monoclonal Antibody (240354D2), Biotin-Conjugate Recombinant
BR00001221

CD28:B7-1[Biotinylated] Inhibitor Screening Assay Kit
BR00028206
CD80, B7.1, activity assay kit, Strep HRP, streptavidin

CD28:B7-2[Biotinylated] Inhibitor Screening Assay Kit
BR00028192
T-Cell-Specific Surface Glycoprotein, TP44, T-lymphocyte activation antigen CD86, B7.2, FUN-1, B70, BU63, CD86, B72

CD282 (TLR2) Monoclonal Antibody (6C2), Biotin-Conjugate
BR00000467

CD282 (TLR2) Monoclonal Antibody (TL2.1), Biotin-Conjugate
BR00000215

CD283 (TLR3) Monoclonal Antibody (TLR3.7), Biotin-Conjugate
BR00000614

CD284 (TLR4) Monoclonal Antibody (HTA125), Biotin-Conjugate
BR00000436

CD284 (TLR4) Monoclonal Antibody (UT41), Biotin-Conjugate
BR00000470

CD289 (TLR9) Monoclonal Antibody (M9.D6), Biotin-Conjugate
BR00000308

CD29 (Integrin beta 1) Monoclonal Antibody (eBioHMb1-1 (HMb1-1)), Biotin-Conjugate
BR00000128

CD294 (CRTH2) Monoclonal Antibody (BM16), Biotin-Conjugate
BR00000332

CD299 Protein, Human, Recombinant
RHC-CD-3377
37 kDa (predicted)
MGC47866, MGC129964, L-SIGN, LSIGN, HP10347, DC-SIGNR, DCSIGNR, DC-SIGN2, C-type lectin domain family 4 member M, CLEC4M, CD299, CD209L

CD299 Protein, Human, Recombinant (hFc)
RHC-CD-3434
65 kDa (predicted); 65.83 kDa (reducing condition,
MGC47866, MGC129964, L-SIGN, LSIGN, HP10347, DC-SIGNR, DCSIGNR, DC-SIGN2, C-type lectin domain family 4 member M, CLEC4M, CD299, CD209L

CD299 Protein, Human, Recombinant (His & Flag)
RHC-CD-3582
35-40 kDa (reducing condition)
L-SIGN, LSIGN, HP10347, DC-SIGNR, DCSIGNR, DC-SIGN2, C-type lectin domain family 4, member M, CLEC4M, CD299, CD209L1, CD209L

CD3 epsilon Polyclonal Antibody, Biotin-Conjugate
BR00001322

CD3 epsilon/CD3e 1-27 peptide Protein, Cynomolgus, Recombinant (hFc & Avi)
RHC-CD-1908
31.3 kDa (predicted). Due to glycosylation, the pr
TCRE, T3E, IMD18, FLJ18683, CD3-+¦, CD3-epsilon, CD3E/CD3 +¦ 1-27 peptide Protein, CD3E

CD3 epsilon/CD3e 1-27 peptide Protein, Human, Recombinant (hFc & Avi)
RHC-CD-2210
31.3 kDa (predicted). Due to glycosylation, the pr
TCRE, T3E, IMD18, FLJ18683, CD3-+¦, CD3-epsilon, CD3E/CD3 +¦ 1-27 peptide Protein, CD3E

CD3 epsilon/CD3e epsilon 1-27 peptide Protein, Cynomolgus, Recombinant (hFc & Avi), Biotinylated
RHC-CD-2054
31.3 kDa (predicted). Due to glycosylation, the pr
TCRE, T3E, IMD18, FLJ18683, CD3-+¦, CD3-epsilon, CD3E/CD3 +¦ 1-27 peptide Protein, CD3E

CD3 epsilon/CD3e Protein (Primary Amine Labeling), Cynomolgus, Recombinant (His), Biotinylated
RHC-CD-2457
11.7 kDa (predicted). Due to glycosylation, the pr
TCRE, T3E, IMD18, FLJ18683, CD3-+¦, CD3-epsilon, CD3E/CD3 +¦, CD3e

CD3 epsilon/CD3e Protein, Canine, Recombinant (hFc)
RHC-CD-2452
38.2 kDa (predicted)
CD3e molecule, +¦ (CD3-TCR complex), CD3e molecule, epsilon (CD3-TCR complex), CD3 +¦/CD3e

CD3 epsilon/CD3e Protein, Cynomolgus, Recombinant (aa 22-117, hFc)
RHC-CD-0500
38-55 kDa (reducing condition)
T-cell surface antigen T3/Leu-4 +¦ chain, T-cell surface antigen T3/Leu-4 epsilon chain, T-cell antigen receptor complex, +¦ subunit of T3, T-cell antigen receptor complex, epsilon subunit of T3, T3E, FLJ18683, CD3-+¦, CD3-epsilon, CD3e molecu

CD3 epsilon/CD3e Protein, Cynomolgus, Recombinant (hFc)
RHC-CD-2015
37.56 kDa (predicted); 46.14 kDa and 41.49 kDa (re
CD3e molecule, +¦ (CD3-TCR complex), CD3e molecule, epsilon (CD3-TCR complex), CD3 +¦/CD3e

CD3 epsilon/CD3e Protein, Cynomolgus, Recombinant (His)
RHC-CD-2061
11.7 kDa (predicted). Due to glycosylation, the pr
TCRE, T3E, IMD18, FLJ18683, CD3-+¦, CD3-epsilon, CD3E/CD3 +¦, CD3e

CD3 epsilon/CD3e Protein, Human, Recombinant (HEK293, His)
RHC-CD-2177
13.2 kDa (predicted); 22.3 kDa (reducing condition
TCRE, T3E, IMD18, CD3e molecule, +¦ (CD3-TCR complex), CD3e molecule, epsilon (CD3-TCR complex), CD3 +¦/CD3e, CD3 +¦, CD3 epsilon

CD3 epsilon/CD3e Protein, Human, Recombinant (hFc & Avi), Biotinylated
RHC-CD-0766
45-60 kDa (reducing condition)
T-Cell Surface Glycoprotein CD3 +¦ Chain, T-Cell Surface Glycoprotein CD3 Epsilon Chain, T-Cell Surface Antigen T3/Leu-4 +¦ Chain, T-Cell Surface Antigen T3/Leu-4 Epsilon Chain, T3E, CD3E

CD3 epsilon/CD3e Protein, Human, Recombinant (hFc)
RHC-CD-2322
38.5 kDa (predicted)
TCRE, T3E, IMD18, CD3e molecule, +¦ (CD3-TCR complex), CD3e molecule, epsilon (CD3-TCR complex), CD3 +¦/CD3e, CD3 +¦, CD3 epsilon

CD3 epsilon/CD3e Protein, Human, Recombinant (His)
RHC-CD-2099
13.2 kDa (predicted); 23.3 kDa (reducing condition
TCRE, T3E, IMD18, CD3e molecule, +¦ (CD3-TCR complex), CD3e molecule, epsilon (CD3-TCR complex), CD3 +¦/CD3e, CD3 +¦, CD3 epsilon

CD3 epsilon/CD3e Protein, Human, Recombinant (His), Biotinylated
RHC-CD-2237
13.2 kDa (predicted)
TCRE, T3E, IMD18, CD3e molecule, +¦ (CD3-TCR complex), CD3e molecule, epsilon (CD3-TCR complex), CD3 +¦/CD3e, CD3 +¦, CD3 epsilon

CD3 epsilon/CD3e Protein, Mouse, Recombinant (His & Myc)
RHC-CD-2079
17.3 kDa (predicted)
T-cell surface glycoprotein CD3 epsilon chain, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e

CD3 epsilon/CD3e Protein, Mouse, Recombinant (His)
RHC-CD-2353
11.9 kDa (predicted)
T-cell surface glycoprotein CD3 epsilon chain, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e

CD3 epsilon/CD3e Protein, Rat, Recombinant (hFc)
RHC-CD-2479
36.1 kDa (predicted)
CD3e molecule, +¦ (CD3-TCR complex), CD3e molecule, epsilon (CD3-TCR complex), CD3 +¦/CD3e

CD3 epsilon/CD3e Protein, Rhesus, Recombinant (hFc)
RHC-CD-2421
38 kDa (predicted)
CD3e molecule, +¦ (CD3-TCR complex), CD3e molecule, epsilon (CD3-TCR complex), CD3 +¦/CD3e

CD3 epsilon/CD3e Protein, Rhesus, Recombinant (His)
RHC-CD-2111
12.3 kDa (predicted)
CD3e molecule, +¦ (CD3-TCR complex), CD3e molecule, epsilon (CD3-TCR complex), CD3 +¦/CD3e

CD3 Gamma Polyclonal Antibody, Biotin-Conjugate
BR00001323

CD3 Monoclonal Antibody (17A2), Biotin-Conjugate
BR00000121

CD3 Monoclonal Antibody (CT-3), Biotin-Conjugate
BR00000922

CD3 Monoclonal Antibody (eBioG4.18 (G4.18)), Biotin-Conjugate
BR00000290

CD3 Monoclonal Antibody (MEM-57), Biotin-Conjugate
BR00000764

CD3 Monoclonal Antibody (OKT3), Biotin-Conjugate
BR00000027

CD3 Monoclonal Antibody (UCHT1), Biotin-Conjugate
BR00000032

CD3 Mouse Monoclonal Antibody (OKT3), Biotin-Conjugate Recombinant
BR00001220

CD3 Mouse Monoclonal Antibody (UCHT1), Biotin-Conjugate Recombinant
BR00001243

CD3 zeta/CD247 Protein, Human, Recombinant
RHC-CD-1149
13.18 kDa (predicted)
TCRZ, T3Z, IMD25, CD3-+¦, CD3-ZETA, CD3Z, CD3Q, CD3H, CD3 +¦/CD247, CD247 molecule

CD3 zeta/CD247 Protein, Human, Recombinant (GST)
RHC-CD-0888
40.2 kDa (predicted); 28-43 kDa (reducing conditio
TCRZ, T3Z, IMD25, CD3-+¦, CD3-ZETA, CD3Z, CD3Q, CD3H, CD3 +¦/CD247, CD247 molecule

CD30 Ligand/TNFSF8 Protein, Human, Recombinant (His)
RHC-CD-2352
20.7 kDa (predicted). Due to glycosylation, the pr
TNFSF8, CD30LGMGC138144, CD30LG, CD30-L, CD30L, CD30 Ligand, CD153

CD30 Monoclonal Antibody (mCD30.1), Biotin-Conjugate
BR00000917

CD30/TNFRSF8 HUMAN
IAR42413187

CD30/TNFRSF8 Protein, Cynomolgus, Recombinant (His)
RHC-CART-0329
21.4 kDa (predicted); 37-41 kDa (reducing conditio
tumor necrosis factor receptor superfamily, member 8

CD30/TNFRSF8 Protein, Human, Recombinant (aa 19-379, hFc)
RHC-CART-0295
90-120 kDa (reducing condition)
Tumor necrosis factor receptor superfamily member 8, TNFRSF8, Lymphocyte activation antigen CD30, Ki-1 antigen, CD30L receptor, CD30

CD30/TNFRSF8 Protein, Human, Recombinant (aa 19-379, His & Avi), Biotinylated
RHC-CART-0292
60-90 kDa (reducing condition)
Tumor necrosis factor receptor superfamily member 8, TNFRSF8, Lymphocyte activation antigen CD30, Ki-1 antigen, CD30L receptor, CD30

CD30/TNFRSF8 Protein, Human, Recombinant (aa 19-379, His)
RHC-CART-0318
60-95 kDa (reducing condition)
Tumor necrosis factor receptor superfamily member 8, TNFRSF8, Lymphocyte activation antigen CD30, Ki-1 antigen, CD30L receptor, CD30

CD30/TNFRSF8 Protein, Human, Recombinant (hFc & Avi), Biotinylated
RHC-CART-0381
67.02 kDa (predicted); 110.33 kDa (reducing condit
tumor necrosis factor receptor superfamily, member 8, Ki-1, D1S166E, CD30

CD30/TNFRSF8 Protein, Human, Recombinant (hFc)
RHC-CART-0354
65.2 kDa (predicted)
tumor necrosis factor receptor superfamily, member 8, Ki-1, D1S166E, CD30

CD30/TNFRSF8 Protein, Human, Recombinant (His & Avi)
RHC-CART-0338
41.3 kDa (predicted). Due to glycosylation, the pr
TNFRSF8, D1S166EKi-1, CD30L receptor, CD30KI-1, CD30

CD30/TNFRSF8 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-2813
41.74 kDa (predicted); 78.49 kDa (reducing conditi
tumor necrosis factor receptor superfamily, member 8, Ki-1, D1S166E, CD30

CD30/TNFRSF8 Protein, Human, Recombinant (His)
RHC-CART-0391
40 kDa (predicted); 75-90 kDa (reducing condition,
tumor necrosis factor receptor superfamily, member 8, Ki-1, D1S166E, CD30

CD30/TNFRSF8 Protein, Human, Recombinant (His), Biotinylated
RHC-CART-0425
39.9 kDa (predicted)
tumor necrosis factor receptor superfamily, member 8, Ki-1, D1S166E, CD30

CD30/TNFRSF8 Protein, Human, Recombinant (mFc)
RHC-CART-0266
90-120 kDa (reducing condition)
Tumor necrosis factor receptor superfamily member 8, TNFRSF8, Lymphocyte activation antigen CD30, Ki-1 antigen, CD30L receptor, CD30

CD30/TNFRSF8 Protein, Mouse, Recombinant (hFc)
RHC-CART-0380
51.92 kDa (predicted)
tumor necrosis factor receptor superfamily, member 8, Ki-1, Ki, D1S166E, Cd30

CD30/TNFRSF8 Protein, Mouse, Recombinant (His)
RHC-CART-0345
26.6 kDa (predicted)
tumor necrosis factor receptor superfamily, member 8, Ki-1, Ki, D1S166E, Cd30

CD300 Polyclonal Antibody, Biotin-Conjugate
BR00001535

CD300A HUMAN
IAR42413165

CD300A Protein, Cynomolgus, Recombinant (Avi)
RHC-CD-1927
19.44 kDa (predicted). Due to glycosylation, the p
Pigr4, NKRL, Mcipr1, MAIR-I, LMIR1, IRp60, IRC1, IGSF12, CLM-8, CLM8, CD300a

CD300A Protein, Cynomolgus, Recombinant (Avi), Biotinylated
RHC-CD-1895
19.44 kDa (predicted). Due to glycosylation, the p
Pigr4, NKRL, Mcipr1, MAIR-I, LMIR1, IRp60, IRC1, IGSF12, CLM-8, CLM8, CD300a

CD300A Protein, Cynomolgus, Recombinant (His)
RHC-CD-1910
18.73 kDa (predicted). Due to glycosylation, the p
Pigr4, NKRL, Mcipr1, MAIR-I, LMIR1, IRp60, IRC1, IGSF12, CLM-8, CLM8, CD300a

CD300A Protein, Human, Recombinant (Avi)
RHC-CD-1896
19.46 kDa (predicted). Due to glycosylation, the p
Pigr4, NKRL, Mcipr1, MAIR-I, LMIR1, IRp60, IRC1, IGSF12, CLM-8, CLM8, CD300a

CD300A Protein, Human, Recombinant (Avi), Biotinylated
RHC-CD-2028
19.46 kDa (predicted). Due to glycosylation, the p
Pigr4, NKRL, Mcipr1, MAIR-I, LMIR1, IRp60, IRC1, IGSF12, CLM-8, CLM8, CD300a

CD300A Protein, Human, Recombinant (hFc & His)
RHC-CD-2228
60-75 kDa (reducing condition)
NK inhibitory receptor, IRC1/IRC2, Inhibitory receptor protein 60, Immunoglobulin superfamily member 12, CMRF35-like molecule 8, CMRF-35-H9, CMRF35-H, CD300 antigen-like family member A

CD300A Protein, Human, Recombinant (hFc)
RHC-CD-2492
44.5 kDa (predicted); 58-66 kDa (reducing conditio
IRp60, IRC2, IRC1/IRC2, IRC1, IGSF12, CMRF35-H9, CMRF-35-H9, CMRF35H9, CMRF35-H, CMRF-35H, CMRF35H, CLM-8, CD300a molecule

CD300A Protein, Human, Recombinant (His)
RHC-CD-1878
18.8 kDa (predicted); 33-43 kDa (reducing conditio
IRp60, IRC2, IRC1/IRC2, IRC1, IGSF12, CMRF35-H9, CMRF-35-H9, CMRF35H9, CMRF35-H, CMRF-35H, CMRF35H, CLM-8, CD300a molecule

CD300A Protein, Mouse, Recombinant (hFc)
RHC-CD-2312
44.2 kDa (predicted); 55-65 kDa (reducing conditio
Pigr4, MMAC8, mcpir1, MAIR-Ia, MAIR-I, LMIR1, Clm8, CD300a molecule, B230315M08Rik

CD300A Protein, Mouse, Recombinant (His)
RHC-CD-2473
20 kDa (predicted). Due to glycosylation, the prot
Pigr4, NKRL, Mcipr1, MAIR-I, LMIR1, IRp60, IRC1, IGSF12, CLM-8, CLM8, CD300a

CD300C HUMAN
IAR42413154

CD300E Protein, Human, Recombinant (hFc)
RHC-CD-2290
44.3 kDa (predicted)
PIgR-2, PIgR2, IREM-2, IREM2, CMRF35-A5, CLM-2, CLM2, CD300LE, CD300e molecule

CD300F/CD300LF Protein, Human, Recombinant (hFc)
RHC-CD-2149
42.1 kDa (predicted)
NKIR, LMIR3, IREM-1, IREM1, IgSF13, CLM-1, CLM1, CD300f, CD300 molecule-like family member f

CD300F/CD300LF Protein, Human, Recombinant (His)
RHC-CD-2516
16.9 kDa (predicted)
NKIR, LMIR3, IREM-1, IREM1, IgSF13, CLM-1, CLM1, CD300f, CD300 molecule-like family member f

CD300F/CD300LF Protein, Mouse, Recombinant (mFc)
RHC-CD-2428
45.3 kDa (predicted)
RP23-342L24.3, Pigr3, LMIR3, IREM1, IgSF13, F730004D16Rik, Digr2, CLM-1, CLM1, CLIM1, CD300 molecule-like family member f

CD300f/CD300LF Protein, Rat, Recombinant (His & Myc & SUMO)
RHC-CD-2064
38.3 kDa (predicted)
CMRF35-like molecule 1, CLM-1, Clm1, Cd300lf, CD300f, CD300 antigen-like family member F

CD300LB Protein, Human, Recombinant (hFc)
RHC-CD-2069
42.2 kDa (predicted)
TREM-5, TREM5, IREM-3, IREM3, CMRF35-A2, CLM-7, CLM7, CD300b, CD300 molecule-like family member b

CD300LB Protein, Human, Recombinant (His)
RHC-CD-2080
18.8 kDa (predicted)
Triggering receptor expressed on myeloid cells 5, TREM-5, TREM5, LMIR5, Leukocyte mono-Ig-like receptor 5, IREM-3, IREM3, Immune receptor expressed on myeloid cells 3, CMRF35-like molecule 7, CMRF35-A2, CMRF35A2, CLM-7, CLM7, CD300LB, CD300

CD302 Protein, Mouse, Recombinant (hFc)
RHC-CD-3476
42.6 kDa (predicted); 48 kDa (reducing condition,
CD302 molecule, AI159627, 1110055L24Rik

CD302 Protein, Mouse, Recombinant (His)
RHC-CD-3432
17 kDa (predicted); 23 kDa (reducing condition, du
CD302 molecule, AI159627, 1110055L24Rik

CD302 Protein, Rat, Recombinant (hFc)
RHC-CD-3370
43.7 kDa (predicted); 47 kDa (reducing conditions)
CD302 molecule

CD302 Protein, Rat, Recombinant (His)
RHC-CD-3546
18.1 kDa (predicted); 18 and 22 kDa (reducing cond
CD302 molecule

CD304/NRP1/NEUROPHILIN-1 HUMAN
IAR42413173

CD306/LAIR2 HUMAN
IAR42413175

CD309 (FLK1) Monoclonal Antibody (Avas12a1), Biotin-Conjugate
BR00000139

CD30L Protein, Cynomolgus, Recombinant (hFc)
RHC-CD-2277
48.1 kDa (predicted); 59 kDa (reducing conditions)
tumor necrosis factor (ligand) superfamily, member 8

CD30L Protein, Cynomolgus, Recombinant (His)
RHC-CD-2396
22 kDa (predicted); 38 kDa (reducing conditions)
tumor necrosis factor (ligand) superfamily, member 8

CD30L Protein, Human, Recombinant
RHC-CD-2425
19.6 kDa (predicted)
tumor necrosis factor (ligand) superfamily, member 8, CD30LG, CD30L, CD153

CD30L Protein, Human, Recombinant (hFc)
RHC-CD-1952
47.8 kDa (predicted); 60-65 kDa (reducing conditio
tumor necrosis factor (ligand) superfamily, member 8, CD30LG, CD30L, CD153

CD30L Protein, Rat, Recombinant
RHC-CD-2002
19.6 kDa (predicted); 31-35 kDa (reducing conditio
tumor necrosis factor (ligand) superfamily, member 8

CD30L Protein, Rat, Recombinant (hFc)
RHC-CD-2366
47.9 kDa (predicted); 58 kDa (reducing condition,
tumor necrosis factor (ligand) superfamily, member 8

CD31 (PECAM-1) Monoclonal Antibody (390), Biotin-Conjugate
BR00000015

CD31 (PECAM-1) Monoclonal Antibody (Gi18), Biotin-Conjugate
BR00000273

CD31 (PECAM-1) Monoclonal Antibody (TLD-3A12), Biotin-Conjugate
BR00000340

CD31 (PECAM-1) Monoclonal Antibody (WM-59 (WM59)), Biotin-Conjugate
BR00000029

CD31 Monoclonal Antibody (LCI-4), Biotin-Conjugate
BR00001116

CD31 Monoclonal Antibody (MBC78.2), Biotin-Conjugate
BR00000747

CD31 Monoclonal Antibody (MEM-05), Biotin-Conjugate
BR00000107

CD31 Monoclonal Antibody (TLD-3A12), Biotin-Conjugate
BR00001145

CD31 Monoclonal Antibody (WM59), Biotin-Conjugate
BR00000279

CD31/PECAM-1 Protein, Cynomolgus, Recombinant (His)
RHC-CD-1928
65.30 kDa (predicted). Due to glycosylation, the p
PECAM-1, PECA1, GPIIA, FLJ58394, FLJ34100, EndoCAM, CD31

CD31/PECAM-1 Protein, Human, Recombinant (aa 28-601, hFc)
RHC-CD-2462
91.2 kDa (predicted). Due to glycosylation, the pr
PECAM-1, PECA1, GPIIA, FLJ58394, FLJ34100, EndoCAM, CD31

CD31/PECAM-1 Protein, Human, Recombinant (aa 28-601, His)
RHC-CD-1938
65.6 kDa (predicted). Due to glycosylation, the pr
PECAM-1, PECA1, GPIIA, FLJ58394, FLJ34100, EndoCAM, CD31

CD31/PECAM-1 Protein, Human, Recombinant (hFc)
RHC-CD-2136
91.2 kDa (predicted); 130-140 kDa (reducing condit
platelet/endothelial cell adhesion molecule 1, PECAM-1, PECA1, GPIIA, endoCAM, CD31/EndoCAM, CD31

CD31/PECAM-1 Protein, Human, Recombinant (His)
RHC-CD-1997
66 kDa (predicted); 100-110 kDa (reducing conditio
platelet/endothelial cell adhesion molecule 1, PECAM-1, PECA1, GPIIA, endoCAM, CD31/EndoCAM, CD31

CD31/PECAM-1 Protein, Mouse, Recombinant (His)
RHC-CD-2415
66 kDa (predicted); 85-95 kDa (reducing conditions
platelet/endothelial cell adhesion molecule 1, PECAM-1, Pecam, Cd31, C85791

CD314 (NKG2D) Monoclonal Antibody (1D11), Biotin-Conjugate
BR00000318

CD314 (NKG2D) Monoclonal Antibody (A10), Biotin-Conjugate
BR00000725

CD316 Protein, Human, Recombinant (hFc)
RHC-CD-3356
90-120 kDa (reducing condition)
Prostaglandin Regulatory-Like Protein, PGRL, LIR-D1, Keratinocytes-Associated Transmembrane Protein 4, KCT-4, KCT4, Immunoglobulin Superfamily Member 8, IGSF8, Glu-Trp-Ile EWI Motif-Containing Protein 2, EWI-2, EWI2, CD81P3, CD81 Partner 3,

CD317 (BST2, PDCA-1) Monoclonal Antibody (eBio927), Biotin-Conjugate
BR00000337

CD319/SLAMF7/CRACC HUMAN
IAR42413174

CD32 Monoclonal Antibody (6C4 (CD32)), Biotin-Conjugate
BR00000669

CD320 Protein, Mouse, Recombinant (hFc)
RHC-CD-3395
46.5 kDa (predicted); 72.5 kDa (reducing condition
VLDL, TCblR, NG29, D17Ertd716e, CD320 molecule, 8D6, 425O18-1

CD320 Protein, Mouse, Recombinant (His)
RHC-CD-3394
21 kDa (predicted); 47.7 kDa (reducing conditions)
VLDL, TCblR, NG29, D17Ertd716e, CD320 molecule, 8D6, 425O18-1

CD320 Protein, Rat, Recombinant (hFc)
RHC-CD-3517
47.3 kDa (predicted)
CD320 molecule

CD323 (JAM3) Monoclonal Antibody (CRAM-19 H36), Biotin-Conjugate
BR00001181

CD324 (E-Cadherin) Monoclonal Antibody (DECMA-1), Biotin-Conjugate
BR00000147

CD325 (N-Cadherin) Monoclonal Antibody (8C11), Biotin-Conjugate
BR00000442

CD326 (EpCAM) Monoclonal Antibody (1B7), Biotin-Conjugate
BR00000187

CD326 (EpCAM) Monoclonal Antibody (G8.8), Biotin-Conjugate
BR00000117

CD32A Protein, Cynomolgus, Recombinant (hFc)
RHC-CD-2252
48.04 kDa (predicted); 57.65 kDa (reducing conditi
Fc fragment of IgG receptor IIa

CD32A Protein, Cynomolgus, Recombinant (His & Avi), Biotinylated
RHC-CD-2377
22.9 kDa (predicted); 33-35 kDa (reducing conditio
Fc fragment of IgG receptor IIa

CD32A Protein, Cynomolgus, Recombinant (His)
RHC-CD-2187
21.8 kDa (predicted); 28-33 kDa (reducing conditio
Fc fragment of IgG receptor IIa

CD32A Protein, Human, Recombinant (167 Arg, hFc)
RHC-CD-2289
47.3 kDa (predicted); 55 kDa (reducing condition,
IGFR2, FCGR2A1, FCGR2, FcGR, FCG2, Fc +¦ RIIA, Fc gamma RIIA, Fc fragment of IgG receptor IIa, CDw32, CD32A, CD32

CD32A Protein, Human, Recombinant (167 Arg, His & Avi), Biotinylated
RHC-CD-2106
23.7 kDa (predicted); 32 kDa (reducing condition,
IGFR2, FCGR2A1, FCGR2, FcGR, FCG2, Fc +¦ RIIA, Fc gamma RIIA, Fc fragment of IgG receptor IIa, CDw32, CD32A, CD32

CD32A Protein, Human, Recombinant (167 Arg, His)
RHC-CD-2137
22 kDa (predicted); 30 kDa (reducing condition, du
IGFR2, FCGR2A1, FCGR2, FcGR, FCG2, Fc +¦ RIIA, Fc gamma RIIA, Fc fragment of IgG receptor IIa, CDw32, CD32A, CD32

CD32A Protein, Human, Recombinant (167 His, His)
RHC-CD-1877
22 kDa (predicted); 30 kDa (reducing condition, du
IGFR2, FCGR2A1, FCGR2, FcGR, FCG2, Fc +¦ RIIA, Fc gamma RIIA, Fc fragment of IgG receptor IIa, CDw32, CD32A, CD32

CD32A Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-2506
23.7 kDa (predicted); 33 kDa (reducing condition,
IGFR2, FCGR2A1, FCGR2, FcGR, FCG2, Fc +¦ RIIA, Fc gamma RIIA, Fc fragment of IgG receptor IIa, CDw32, CD32A, CD32

CD32A Protein, Human, Recombinant (R167, His)
RHC-CD-2232
25-32 kDa (reducing condition)
Low Affinity Immunoglobulin +¦ Fc Region Receptor II-a, Low Affinity Immunoglobulin Gamma Fc Region Receptor II-a, IgG Fc receptor II-a, IGFR2, Fc-+¦-RIIa, Fc-+¦ RII-a, FcRII-a, FCGR2A1, FCGR2A, Fc-Gamma-RIIa, Fc-Gamma RII-a, FCG2, CDw32, CD32

CD32A Protein, Rat, Recombinant (hFc)
RHC-CD-2276
47.5 kDa (predicted)
Fc fragment of IgG receptor IIa

CD32A Protein, Rat, Recombinant (His)
RHC-CD-3305
22.2 kDa (predicted)
Fc fragment of IgG receptor IIa

CD32A Protein, Rhesus, Recombinant (His & Avi), Biotinylated
RHC-CD-2388
23.67 kDa (predicted); 33.32 kDa (reducing conditi
Fc fragment of IgG receptor IIa

CD32A Protein, Rhesus, Recombinant (His)
RHC-CD-1965
21.7 kDa (predicted)
Fc fragment of IgG receptor IIa

CD32B/Fcgr2b Protein, Cynomolgus, Recombinant (His & Avi), Biotinylated
RHC-CD-1642
23.5 kDa (predicted); 34 kDa (reducing condition,
Fc fragment of IgG, low affinity IIb, receptor (CD32)

CD32B/Fcgr2b Protein, Cynomolgus, Recombinant (His)
RHC-CD-1752
20.9 kDa (predicted); 28-33 kDa (reducing conditio
Fc fragment of IgG, low affinity IIb, receptor (CD32)

CD32B/Fcgr2b Protein, Human, Recombinant (His & Avi)
RHC-RP-1971
22.5 kDa (predicted). Due to glycosylation, the pr
IGFR2, FCGR2A, FCGR21, FCGR2, FcGR, FCG2, Fc +¦ RIIB, Fc +¦ RII, Fc gamma RIIB, Fc gamma RII, CDw32, CD32b, CD32A, CD32

CD32B/Fcgr2b Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-1436
24 kDa (predicted); 35 kDa (reducing condition, du
IGFR2, FCGR2A, FCGR21, FCGR2, FcGR, FCG2, Fc +¦ RIIB, Fc +¦ RII, Fc gamma RIIB, Fc gamma RII, Fc fragment of IgG, low affinity IIb, receptor (CD32), CDw32, CD32B, CD32A, CD32

CD32B/Fcgr2b Protein, Human, Recombinant (His)
RHC-CD-1417
22-30 kDa (reducing condition)
Low Affinity Immunoglobulin +¦ Fc Region Receptor II-b, Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b, IgG Fc Receptor II-b, IGFR2, Fc-+¦-RIIb, Fc-+¦ RII-b, FcRII-b, FCGR2B, Fc-Gamma-RIIb, Fc-Gamma RII-b, FCG2, CDw32, CD32

CD32B/Fcgr2b Protein, Human, Recombinant (IIB2, His)
RHC-CD-1517
20.8 kDa (predicted); 25-30 kDa (reducing conditio
IGFR2, FCGR2A, FCGR21, FCGR2, FcGR, FCG2, Fc +¦ RIIB, Fc +¦ RII, Fc gamma RIIB, Fc gamma RII, Fc fragment of IgG, low affinity IIb, receptor (CD32), CDw32, CD32B, CD32A, CD32

CD32B/Fcgr2b Protein, Mouse, Recombinant (His & Avi), Biotinylated
RHC-CD-1688
23.9 kDa (predicted); 38-43 kDa (reducing conditio
Ly-m20, LyM-1, Ly-17, fcRII, Fcr-3, Fcr-2, FcgRII, Fcgr2a, Fcgr2, Fc[g]RII, Fc fragment of IgG, low affinity IIb, receptor (CD32), F630109E10Rik, CD32, AI528646

CD32B/Fcgr2b Protein, Mouse, Recombinant (His)
RHC-CD-1516
21.7 kDa (predicted); 34 kDa (reducing condition,
Ly-m20, LyM-1, Ly-17, fcRII, Fcr-3, Fcr-2, FcgRII, Fcgr2a, Fcgr2, Fc[g]RII, Fc fragment of IgG, low affinity IIb, receptor (CD32), F630109E10Rik, CD32, AI528646

CD32B/Fcgr2b Protein, Rat, Recombinant (His)
RHC-CD-1603
21.9 kDa (predicted); 35-40 kDa (reducing conditio
Fc fragment of IgG, low affinity IIb, receptor (CD32)

CD33 Monoclonal Antibody (HIM3-4), Biotin-Conjugate
BR00000687

CD33 Monoclonal Antibody (OTI1B10), Biotin-Conjugate
BR00001383

CD33 Monoclonal Antibody (OTI1C4), Biotin-Conjugate
BR00001583

CD33 Monoclonal Antibody (OTI1E10), Biotin-Conjugate
BR00001434

CD33 Monoclonal Antibody (OTI2E4), Biotin-Conjugate
BR00001581

CD33 Monoclonal Antibody (OTI2F8), Biotin-Conjugate
BR00001582

CD33 Polyclonal Antibody, Biotin-Conjugate
BR00002659

CD335 (NKp46) Monoclonal Antibody (29A1.4), Biotin-Conjugate
BR00000220

CD338 (ABCG2) Monoclonal Antibody (5D3), Biotin-Conjugate
BR00000227

CD34 (soluble) Polyclonal Antibody, Biotin-Conjugate
BR00000592

CD34 Monoclonal Antibody (1H6), Biotin-Conjugate
BR00001172

CD34 Monoclonal Antibody (4H11), Biotin-Conjugate
BR00000133

CD34 Monoclonal Antibody (4H11[APG]), Biotin-Conjugate
BR00000836

CD34 Monoclonal Antibody (581), Biotin-Conjugate
BR00000263

CD34 Monoclonal Antibody (MEC14.7), Biotin-Conjugate
BR00000887

CD34 Monoclonal Antibody (QBEND/10), Biotin-Conjugate
BR00000718

CD34 Monoclonal Antibody (RAM34), Biotin-Conjugate
BR00000113

CD34 Protein, Human, Recombinant (hFc)
RHC-CD-0331
54 kDa (predicted); 116 and 96 kDa (reducing condi
CD34 molecule

CD34 Protein, Human, Recombinant (hFc), Biotinylated
RHC-CD-0025
54 kDa (predicted)
CD34 molecule

CD34 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-0061
30.75 kDa (predicted); 73.17 kDa (reducing conditi
CD34 molecule

CD34 Protein, Human, Recombinant (His)
RHC-CD-0276
29 kDa (predicted); 72.33 kDa (reducing condition,
CD34 molecule

CD34 Protein, Mouse, Recombinant (hFc)
RHC-CD-0198
53.92 kDa (predicted); 99.45 kDa and 73.90 kDa (re
CD34 molecule, AU040960

CD34 Protein, Mouse, Recombinant (His)
RHC-CD-0018
28.6 kDa (predicted); 50-60 kDa (reducing conditio
CD34 molecule, AU040960

CD34 Protein, Rat, Recombinant (hFc)
RHC-CD-0256
54.5 kDa (predicted); 112 kDa (reducing conditions
CD34 molecule

CD35 Monoclonal Antibody (To5), Biotin-Conjugate
BR00000775

CD357 (AITR/GITR) Monoclonal Antibody (DTA-1), Biotin-Conjugate
BR00000359

CD357 (AITR/GITR) Monoclonal Antibody (YGITR765.4.16), Biotin-Conjugate
BR00000904

CD36 HUMAN
IAR42413170

CD36 Monoclonal Antibody (OTI3F4), Biotin-Conjugate
BR00001867

CD36 Monoclonal Antibody (OTI4H7), Biotin-Conjugate
BR00001668

CD36 Monoclonal Antibody (TR9), Biotin-Conjugate
BR00000789

CD36 Polyclonal Antibody, Biotin-Conjugate
BR00001240

CD36 Protein, Cynomolgus, Recombinant (His)
RHC-CD-1371
47.67 kDa (predicted). Due to glycosylation, the p
SR-B3, SRB3, SCARB3, PAS-4, PAS IV, GPIV, GPIIIb, GP3B, FATCHDS7, FAT, CHDS7, CD36, BDPLT10

CD36 Protein, Human, Recombinant (aa 27-432, His)
RHC-VP-1458
55-85 kDa (reducing condition)
Scavenger Receptor Class B Member 2, SCARB2, Lysosome Membrane Protein II, Lysosome Membrane Protein 2, LIMPII, LIMP II, LGP85, CD36L2, CD36 Antigen-Like 2, CD36, 85 kDa Lysosomal Membrane Sialoglycoprotein

CD36 Protein, Human, Recombinant (hFc)
RHC-CD-1382
90-130 kDa (reducing condition)
Thrombospondin receptor, SCARB3, Platelet collagen receptor, PAS IV, Leukocyte differentiation antigen CD36, Glycoprotein IIIb, Fatty acid translocase, FATCHDS7, CD36

CD36 Protein, Human, Recombinant (His & Avi)
RHC-CD-1759
49.5 kDa (predicted). Due to glycosylation, the pr
SR-B3, SRB3, SCARB3, PAS-4, PAS IV, GPIV, GPIIIb, GP3B, FATCHDS7, FAT, CHDS7, CD36, BDPLT10

CD36 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-1702
49.88 kDa (predicted); 60.9 kDa (reducing conditio
SCARB3, PASIV, GPIV, GP4, GP3B, FAT, CHDS7, CD36 molecule (thrombospondin receptor), BDPLT10

CD36 Protein, Human, Recombinant (His)
RHC-CD-1632
48.1 kDa (predicted); 62.6 kDa (reducing condition
SCARB3, PASIV, GPIV, GP4, GP3B, FAT, CHDS7, CD36 molecule (thrombospondin receptor), BDPLT10

CD36 Protein, Mouse, Recombinant (Avi & His), Biotinylated
RHC-CD-2324
85-120 kDa (reducing condition)
Platelet glycoprotein IV, PAS-4, PAS IV, GPIV, GPIIIB, Glycoprotein IIIb, CD36

CD36 Protein, Mouse, Recombinant (hFc)
RHC-CD-1761
100-130 kDa (reducing condition)
Platelet glycoprotein IV, PAS-4, PAS IV, GPIV, GPIIIB, Glycoprotein IIIb, CD36

CD36 Protein, Mouse, Recombinant (His & hFc)
RHC-CD-1606
74.5 kDa (predicted); 110-120 kDa (reducing condit
Scarb3, GPIV, FAT, CD36 molecule (thrombospondin receptor)

CD36 Protein, Mouse, Recombinant (His)
RHC-CD-1588
47.8 kDa (predicted); 80-90 kDa (reducing conditio
Scarb3, GPIV, FAT, CD36 molecule (thrombospondin receptor)

CD36 Protein, Rat, Recombinant (hFc)
RHC-CD-1422
73.3 kDa (predicted); 108 kDa (reducing conditions
CD36 molecule (thrombospondin receptor)

CD36 Protein, Rat, Recombinant (His)
RHC-CD-1313
47.8 kDa (predicted); 68 kDa (reducing condition,
CD36 molecule (thrombospondin receptor)

CD36 Protein, Rhesus, Recombinant (hFc)
RHC-CD-1514
73.6 kDa (predicted)
CD36 molecule (thrombospondin receptor)

CD360 (IL-21 Receptor) Monoclonal Antibody (eBio4A9), Biotin-Conjugate
BR00000066

CD365 (Tim-1) Monoclonal Antibody (RMT1-4), Biotin-Conjugate
BR00000662

CD366 (TIM3) Monoclonal Antibody (8B.2C12), Biotin-Conjugate
BR00000053

CD37 Protein, Bovine, Recombinant (His)
RHC-CD-0137
37.8 kDa (predicted)
Leukocyte antigen CD37, CD37

CD37 Protein, Human, Recombinant (hFc)
RHC-CD-0028
41.62 kDa (predicted); 51.18 kDa (reducing conditi
TSPAN26, GP52-40, CD37 molecule

CD37 Protein, Human, Recombinant (His)
RHC-CD-0239
15.72 kDa (predicted). Due to glycosylation, the p
Tspan-26, Tetraspanin-26, MGC120234, GP52-40, CD37 molecule, CD37

CD37 Protein, Mouse, Recombinant (hFc)
RHC-CD-0196
43.6 kDa (predicted)
Tspan26, CD37 molecule

CD38 Monoclonal Antibody (90), Biotin-Conjugate
BR00000207

CD38 Monoclonal Antibody (HIT2), Biotin-Conjugate
BR00000223

CD38 Polyclonal Antibody, Biotin-Conjugate
BR00002688

CD38 Protein, Cynomolgus, Rhesus, Recombinant (hFc)
RHC-CART-0279
56.9 kDa (predicted)
CD38 molecule

CD38 Protein, Cynomolgus, Rhesus, Recombinant (His)
RHC-CART-0389
31.3 kDa (predicted); 41 kDa (reducing conditions)
CD38 molecule

CD38 Protein, Human, Recombinant (hFc & Avi), Biotinylated
RHC-CD-1286
58.41 kDa (predicted); 65.85 kDa (reducing conditi
T10, CD38 molecule, ADPRC1, ADPRC 1

CD38 Protein, Human, Recombinant (hFc)
RHC-CART-0341
56.6 kDa (predicted); 64.7 kDa (reducing condition
T10, CD38 molecule, ADPRC1, ADPRC 1

CD38 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CART-0421
33.1 kDa (predicted)
T10, CD38 molecule, ADPRC1, ADPRC 1

CD38 Protein, Human, Recombinant (His & FLAG)
RHC-CART-0322
33.2 kDa (predicted); 42-45 kDa (reducing conditio
T10, CD38 molecule, ADPRC1, ADPRC 1

CD38 Protein, Human, Recombinant (His)
RHC-CART-0243
31.3 kDa (predicted); 43-45 kDa (reducing conditio
T10, CD38 molecule, ADPRC1, ADPRC 1

CD38 Protein, Human, Recombinant (His), FITC conjugated
RHC-CART-0358
T10, CD38 molecule, ADPRC1, ADPRC 1

CD38 Protein, Human, Recombinant (His), PE conjugated
RHC-CART-0357
T10, CD38 molecule, ADPRC1, ADPRC 1

CD38 Protein, Mouse, Recombinant
RHC-CART-0403
29.80 kDa (predicted); 37.9 kDa (reducing conditio
I-19, Cd38-rs1, CD38 molecule, Cd38, ADPRC1, ADPRC 1-rs1

CD38 Protein, Mouse, Recombinant (hFc)
RHC-CART-0408
70-90 kDa (reducing condition)
T10, cyclic ADP-ribose hydrolase, CD38, ADP-ribosyl cyclase 1

CD38 Protein, Mouse, Recombinant (His)
RHC-CART-0278
31.3 kDa (predicted); 38-42 kDa (reducing conditio
I-19, Cd38-rs1, CD38 molecule, Cd38, ADPRC1, ADPRC 1-rs1

CD38 Protein, Rabbit, Recombinant (His)
RHC-CART-0398
30.5 kDa (predicted); 37-46 kDa (reducing conditio
CD38 molecule, ADPRC1

CD38 Protein, Rat, Recombinant (hFc)
RHC-CART-0379
56.7 kDa (predicted); 67 kDa (reducing conditions)
CD38 molecule

CD38 Protein, Rat, Recombinant (His)
RHC-CART-0309
31.2 kDa (predicted); 42 kDa (reducing condition,
CD38 molecule

CD39 Polyclonal Antibody, Biotin-Conjugate
BR00002900

CD39 Protein, Cynomolgus, Rhesus, Recombinant (His)
RHC-CD-1505
51.8 kDa (predicted)
ectonucleoside triphosphate diphosphohydrolase 1

CD39 Protein, Human, Recombinant (His)
RHC-CD-1294
51.8 kDa (predicted); 56.7 kDa (reducing condition
SPG64, NTPDase-1, ectonucleoside triphosphate diphosphohydrolase 1, CD39, ATPDase

CD39 Protein, Mouse, Recombinant (His)
RHC-CD-1604
51 kDa (predicted)
NTPDase-1, ectonucleoside triphosphate diphosphohydrolase 1, Cd39, AA408691, 2610206B08Rik

CD39 Protein, Rat, Recombinant (E. coli, His)
RHC-CD-1451
50.6 kDa (predicted)
Nucleoside triphosphate diphosphohydrolase 1, NTPDase1, Lymphoid cell activation antigen, Entpd1, Ectonucleoside triphosphate diphosphohydrolase 1, Ecto-ATPDase 1, Ecto-ATPase 1, Ecto-ATP diphosphohydrolase 1, Ecto-apyrase, CD39, ATP-DPH, A

CD39 Protein, Rat, Recombinant (His)
RHC-CD-1484
50.9 kDa (predicted)
Nucleoside triphosphate diphosphohydrolase 1, NTPDase1, Lymphoid cell activation antigen, Entpd1, Ectonucleoside triphosphate diphosphohydrolase 1, Ecto-ATPDase 1, Ecto-ATPase 1, Ecto-ATP diphosphohydrolase 1, Ecto-apyrase, CD39, ATP-DPH, A

CD39L1 Protein, Mouse, Recombinant (His)
RHC-ENZY-2210
63-90 kDa (reducing condition)
Entpd2, Ectonucleoside triphosphate diphosphohydrolase 2

Cd3As2 Crystal
ACMA00023096

CD3D & CD3E Heterodimer Protein, Cynomolgus, Recombinant
RHC-CD-1000
76.63 kDa (predicted); (50.99&40.83) kDa (reducing
CD3d molecule, +¦ (CD3-TCR complex), CD3d molecule, delta (CD3-TCR complex)

CD3D & CD3E Heterodimer Protein, Human, Recombinant
RHC-CD-0976
77.5 kDa (predicted); 44-54 kDa (reducing conditio
T3D, IMD19, CD3-+¦, CD3-DELTA, CD3d molecule, +¦ (CD3-TCR complex), CD3d molecule, delta (CD3-TCR complex)

CD3D & CD3E Heterodimer Protein, Human, Recombinant (Flag & His)
RHC-CD-1125
31.05 kDa (predicted); 20, 22 and 26 kDa (reducing
T3D, IMD19, CD3-+¦, CD3-DELTA, CD3d molecule, +¦ (CD3-TCR complex), CD3d molecule, delta (CD3-TCR complex)

CD3D & CD3E Heterodimer Protein, Human, Recombinant (Flag & His), Biotinylated
RHC-CD-1290
31.05 kDa (predicted)
T3D, IMD19, CD3-+¦, CD3-DELTA, CD3d molecule, +¦ (CD3-TCR complex), CD3d molecule, delta (CD3-TCR complex)

CD3D & CD3E Heterodimer Protein, Human, Recombinant (His)
RHC-CD-1202
22.75 kDa (predicted); 28.70 kDa , 20.22 kDa and 1
T3D, IMD19, CD3-+¦, CD3-DELTA, CD3d molecule, +¦ (CD3-TCR complex), CD3d molecule, delta (CD3-TCR complex)

CD3D & CD3E Heterodimer Protein, Mouse, Recombinant
RHC-CD-0832
75.4 kDa (predicted); 36-55 kDa (reducing conditio
T3d, CD3d molecule, +¦ (CD3-TCR complex), CD3d molecule, delta (CD3-TCR complex)

CD3D & CD3E Heterodimer Protein, Mouse, Recombinant (Fc-Flag & Fc-His)
RHC-CD-1212
76 kDa (predicted); 45-50 kDa (reducing condition,
T3d, CD3d molecule, +¦ (CD3-TCR complex), CD3d molecule, delta (CD3-TCR complex)

CD3D & CD3E Heterodimer Protein, Mouse, Recombinant (Flag & His)
RHC-CD-1084
29.2 kDa (predicted); 20 and 22 kDa (reducing cond
T3d, CD3d molecule, +¦ (CD3-TCR complex), CD3d molecule, delta (CD3-TCR complex)

CD3D & CD3E Heterodimer Protein, Rhesus, Recombinant (Fc-Flag & Fc-His)
RHC-CD-1150
76.63 kDa (predicted); 51.18&43.36 kDa (reducing c
CD3d molecule, +¦ (CD3-TCR complex), CD3d molecule, delta (CD3-TCR complex)

CD3D Protein, Canine, Recombinant (hFc)
RHC-CD-1280
36.2 kDa (predicted)
CD3d molecule, +¦ (CD3-TCR complex), CD3d molecule, delta (CD3-TCR complex)

CD3D Protein, Cynomolgus, Recombinant (hFc)
RHC-CD-0724
36.6 kDa (predicted); 44-49 kDa (reducing conditio
CD3d molecule, +¦ (CD3-TCR complex), CD3d molecule, delta (CD3-TCR complex)

CD3D Protein, Cynomolgus, Recombinant (His)
RHC-CD-1278
11 kDa (predicted); 25-35 kDa (reducing condition,
CD3d molecule, +¦ (CD3-TCR complex), CD3d molecule, delta (CD3-TCR complex)

CD3D Protein, Human, Recombinant (hFc & FLAG)
RHC-CD-0445
37.8 kDa (predicted); 47-51 kDa (reducing conditio
T3D, IMD19, CD3-+¦, CD3-DELTA, CD3d molecule, +¦ (CD3-TCR complex), CD3d molecule, delta (CD3-TCR complex), CD3 +¦, CD3 delta

CD3D Protein, Human, Recombinant (hFc & FLAG), Biotinylated
RHC-CD-0776
37.8 kDa (predicted)
T3D, IMD19, CD3-+¦, CD3-DELTA, CD3d molecule, +¦ (CD3-TCR complex), CD3d molecule, delta (CD3-TCR complex), CD3 +¦, CD3 delta

CD3D Protein, Human, Recombinant (His)
RHC-CD-0716
11 kDa (predicted); 20-23 kDa (reducing condition,
T3D, IMD19, CD3-+¦, CD3-DELTA, CD3d molecule, +¦ (CD3-TCR complex), CD3d molecule, delta (CD3-TCR complex), CD3 +¦, CD3 delta

CD3D Protein, Mouse, Recombinant (hFc)
RHC-CD-0648
36.4 kDa (predicted); 44-48 kDa (reducing conditio
T3d, CD3d molecule, +¦ (CD3-TCR complex), CD3d molecule, delta (CD3-TCR complex)

CD3E & CD3G Heterodimer Protein, Cynomolgus, Recombinant (hFc)
RHC-CD-0838
74.9 kDa (predicted)
CD3e molecule, +¦ (CD3-TCR complex), CD3e molecule, epsilon (CD3-TCR complex)

CD3E & CD3G Heterodimer Protein, Human, Recombinant (Fc)
RHC-CD-1039
78.4 kDa (predicted)
TCRE, T3E, IMD18, CD3e molecule, +¦ (CD3-TCR complex), CD3e molecule, epsilon (CD3-TCR complex), CD3E & CD3G Heterodimer

CD3E & CD3G Heterodimer Protein, Human, Recombinant (Fc-Flag & Fc-His)
RHC-CD-1019
78.36 kDa (predicted); 47.10 and 42.93 kDa (reduci
TCRE, T3E, IMD18, CD3e molecule, +¦ (CD3-TCR complex), CD3e molecule, epsilon (CD3-TCR complex), CD3E & CD3G Heterodimer

CD3E & CD3G Heterodimer Protein, Human, Recombinant (Fc-Flag & mFc)
RHC-CD-1217
76.9 kDa (predicted); 42-47 kDa (reducing conditio
TCRE, T3E, IMD18, CD3e molecule, +¦ (CD3-TCR complex), CD3e molecule, epsilon (CD3-TCR complex), CD3E & CD3G Heterodimer

CD3E & CD3G Heterodimer Protein, Mouse, Recombinant (hFc & His)
RHC-CD-1062
75.4 kDa (predicted)
T3e, CD3+¦, CD3epsilon, CD3e molecule, +¦ (CD3-TCR complex), CD3e molecule, epsilon (CD3-TCR complex), CD3, AI504783

CD3E & CD3G Heterodimer Protein, Mouse, Recombinant (hFc)
RHC-CD-1196
74.5 kDa (predicted)
T3e, CD3+¦, CD3epsilon, CD3e molecule, +¦ (CD3-TCR complex), CD3e molecule, epsilon (CD3-TCR complex), CD3, AI504783

CD3E & CD3G Heterodimer Protein, Rhesus, Recombinant (hFc)
RHC-CD-1047
75.4 kDa (predicted)
CD3e molecule, +¦ (CD3-TCR complex), CD3e molecule, epsilon (CD3-TCR complex)

CD3E HUMAN
IAR42413166

CD3e Monoclonal Antibody (145-2C11), Biotin-Conjugate
BR00000101

CD3e Monoclonal Antibody (BB23-8E6), Biotin-Conjugate
BR00000935

CD3e Monoclonal Antibody (eBio500A2 (500A2)), Biotin-Conjugate
BR00000256

CD3e Monoclonal Antibody (FN-18), Biotin-Conjugate
BR00000707

CD3G HUMAN
IAR42413155

CD3G Protein, Cynomolgus, Recombinant (His)
RHC-CD-1164
12.5 kDa (predicted)
T-cell surface glycoprotein CD3 gamma chain, T-cell receptor T3 gamma chain, CD3G

CD3G Protein, Human, Recombinant (His & Myc)
RHC-CD-1016
18.2 kDa (predicted)
T-cell surface glycoprotein CD3 gamma chain, T-cell receptor T3 gamma chain, CD3G

Cd3Sb2 Crystal
ACMA00023097

CD3z Monoclonal Antibody (H146-968), Biotin-Conjugate
BR00001165

CD4 FRAGMENT 25-58
CAS:119112-09-3
ACM119112093

CD4 Monoclonal Antibody (3-4F4), Biotin-Conjugate
BR00000936

CD4 Monoclonal Antibody (4SM95), Biotin-Conjugate
BR00000143

CD4 Monoclonal Antibody (74-12-4), Biotin-Conjugate
BR00000926

CD4 Monoclonal Antibody (7E14), Biotin-Conjugate
BR00001126

CD4 Monoclonal Antibody (CT-4), Biotin-Conjugate
BR00000920

CD4 Monoclonal Antibody (CT-CD4), Biotin-Conjugate
BR00000667

CD4 Monoclonal Antibody (EP96), Biotin-Conjugate
BR00000937

CD4 Monoclonal Antibody (GK1.5), Biotin-Conjugate
BR00000012

CD4 Monoclonal Antibody (MEM-241), Biotin-Conjugate
BR00000772

CD4 Monoclonal Antibody (N1UG0), Biotin-Conjugate
BR00000097

CD4 Monoclonal Antibody (OKT4 (OKT-4)), Biotin-Conjugate
BR00000161

CD4 Monoclonal Antibody (OTI2A7), Biotin-Conjugate
BR00001731

CD4 Monoclonal Antibody (OTI2D4), Biotin-Conjugate
BR00001726

CD4 Monoclonal Antibody (OTI2H8), Biotin-Conjugate
BR00001737

CD4 Monoclonal Antibody (OTI4A9), Biotin-Conjugate
BR00001559

CD4 Monoclonal Antibody (OTI5D9), Biotin-Conjugate
BR00001736

CD4 Monoclonal Antibody (OTI6B7), Biotin-Conjugate
BR00001558

CD4 Monoclonal Antibody (OTI7F2), Biotin-Conjugate
BR00001732

CD4 Monoclonal Antibody (OTI8H3), Biotin-Conjugate
BR00001735

CD4 Monoclonal Antibody (RM4-4), Biotin-Conjugate
BR00000250

CD4 Monoclonal Antibody (RM4-5), Biotin-Conjugate
BR00000016

CD4 Monoclonal Antibody (RPA-T4), Biotin-Conjugate
BR00000021

CD4 Monoclonal Antibody (W3/25), Biotin-Conjugate
BR00000675

CD4 Monoclonal Antibody (YTS191.1), Biotin-Conjugate
BR00000854

CD4 Polyclonal Antibody, Biotin-Conjugate
BR00001357

CD4 Protein, Ferret, Recombinant (His)
RHC-CART-0394
42.7 kDa (predicted); 52 kDa (reducing condition,
CD4 molecule

CD4 Protein, Human, Recombinant (aa 1-208, His)
RHC-CART-0396
21.7 kDa (predicted); 26 kDa (reducing conditions)
CD4mut, CD4 molecule

CD4 Protein, Human, Recombinant (aa 26-390, His & Avi), Biotinylated
RHC-CART-0371
43.6 kDa (predicted). Due to glycosylation, the pr
EU3, CD4mut, CD4 receptor, CD4 molecule, CD4 antigen (p55), CD4

CD4 Protein, Human, Recombinant (hFc)
RHC-CART-0360
67.4 kDa (predicted)
CD4mut, CD4 molecule

CD4 Protein, Human, Recombinant (His & Avi)
RHC-CART-0269
43.6 kDa (predicted). Due to glycosylation, the pr
EU3, CD4mut, CD4 receptor, CD4 molecule, CD4 antigen (p55), CD4

CD4 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-1285
44.56 kDa (predicted); 50.99 kDa (reducing conditi
CD4mut, CD4 molecule

CD4 Protein, Human, Recombinant (His)
RHC-CART-0344
42.2 kDa (predicted); 46 kDa (reducing condition,
CD4mut, CD4 molecule

CD4 Protein, Human, Recombinant (His), Biotinylated
RHC-CART-0370
42.2 kDa (predicted)
CD4mut, CD4 molecule

CD4 Protein, Mouse, Recombinant (hFc)
RHC-CART-0302
67.97 kDa (predicted); 106.04 kDa (reducing condit
Ly-4, L3T4, CD4 molecule

CD4 Protein, Mouse, Recombinant (His & Avi), Biotinylated
RHC-CART-0306
44.51 kDa (predicted); 52.83 kDa (reducing conditi
Ly-4, L3T4, CD4 molecule

CD4 Protein, Mouse, Recombinant (His)
RHC-CART-0323
42.8 kDa (predicted); 50-55 kDa (reducing conditio
Ly-4, L3T4, CD4 molecule

CD4 Protein, Rat, Recombinant (His)
RHC-CART-0301
42.5 kDa (predicted)
CD4 molecule

CD4 Protein, Rhesus, Recombinant (hFc)
RHC-CART-0324
67.4 kDa (predicted)
CD4 molecule

CD4 Protein, Rhesus, Recombinant (His)
RHC-CART-0330
41.8 kDa (predicted)
CD4 molecule

CD4 Rabbit Monoclonal Antibody (OKT4), Biotin-Conjugate Recombinant
BR00001219

CD40 HUMAN
IAR4248413

CD40 Ligand Protein (Primary Amine Labeling), Human, Recombinant (His & Flag), Biotinylated
RHC-CD-2329
52.4 kDa (predicted). Due to glycosylation, the pr
TRAP, TNFSF5IMD3, TNFSF5, T-BAM, IMD3, IGM, HIGM1, gp39, CD40LIGM, CD40LG, CD40L, CD40 Ligand, CD154

CD40 Ligand Protein, Canine, Recombinant
RHC-CD-1995
16 kDa (predicted); 19 kDa (reducing conditions)
CD40 LIGAND

CD40 Ligand Protein, Canine, Recombinant (mFc)
RHC-CD-2110
42.5 kDa (predicted); 47 kDa (reducing conditions)
CD40 LIGAND

CD40 Ligand Protein, Human, Recombinant
RHC-CD-2207
15 kDa (reducing condition)
Tumor Necrosis Factor Ligand Superfamily Member 5, TRAP, TNFSF5, TNF-Related Activation Protein, T-Cell Antigen Gp39, CD40LG, CD40-L, CD40L, CD40 Ligand, CD154

CD40 Ligand Protein, Human, Recombinant (hFc & Avi), Biotinylated
RHC-CD-2390
44.7 kDa (predicted)
TRAP, TNFSF5, T-BAM, IMD3, IGM, HIGM1, hCD40L, gp39, CD40L, CD40 ligand, CD154

CD40 Ligand Protein, Human, Recombinant (hFc)
RHC-CD-1814
42.8 kDa (predicted); 47.8 kDa (reducing condition
TRAP, TNFSF5, T-BAM, IMD3, IGM, HIGM1, hCD40L, gp39, CD40L, CD40 ligand, CD154

CD40 Ligand Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-2063
23-28 kDa (reducing condition)
Tumor Necrosis Factor Ligand Superfamily Member 5, TRAP, TNFSF5, TNF-Related Activation Protein, T-Cell Antigen Gp39, CD40LG, CD40-L, CD40L, CD40 Ligand, CD154

CD40 Ligand Protein, Human, Recombinant (His & Flag)
RHC-CD-2442
19-24 kDa (reducing condition)
Tumor Necrosis Factor Ligand Superfamily Member 5, TRAP, TNFSF5, TNF-Related Activation Protein, T-Cell Antigen Gp39, CD40LG, CD40-L, CD40L, CD40 Ligand, CD154

CD40 Ligand Protein, Human, Recombinant (His)
RHC-CD-2103
17.7 kDa (predicted); 18 kDa (reducing conditions)
TRAP, TNFSF5, T-BAM, IMD3, IGM, HIGM1, hCD40L, gp39, CD40L, CD40 ligand, CD154

CD40 Ligand Protein, Human, Recombinant (Mammalian)
RHC-CD-2227
16-18 kDa (reducing condition)
Tumor Necrosis Factor Ligand Superfamily Member 5, TRAP, TNFSF5, TNF-Related Activation Protein, T-Cell Antigen Gp39, CD40LG, CD40-L, CD40L, CD40 Ligand, CD154

CD40 Ligand Protein, Mouse, Recombinant (aa 112-260, His)
RHC-CD-2062
20 kDa (reducing condition)
Tumor necrosis factor ligand superfamily member 5, tumor necrosis factor (ligand) superfamily member 5, TNFSF5, T-BAM, T-B cell-activating molecule, HIGM1, CD40LG, CD40 Ligand

CD40 Ligand Protein, Mouse, Recombinant (hFc)
RHC-CD-1880
44.4 kDa (predicted); 50 kDa (reducing conditions)
TRAP, Tnfsf5, T-BAM, Ly-62, Ly62, IMD3, IGM, HIGM1, gp39, CD40-L, Cd40l, CD40 ligand, CD154

CD40 Ligand Protein, Mouse, Recombinant (His)
RHC-CD-2513
17.37 kDa (predicted); 22.13 kDa and 19.90 kDa (re
TRAP, Tnfsf5, T-BAM, Ly-62, Ly62, IMD3, IGM, HIGM1, gp39, CD40-L, Cd40l, CD40 ligand, CD154

CD40 Ligand Protein, Mouse, Recombinant (monomeric hFc)
RHC-CD-2201
75.6 kDa (predicted). Due to glycosylation, the pr
TRAP, TNFSF5IMD3, TNFSF5, T-BAM, IMD3, IGM, HIGM1, gp39, CD40LIGM, CD40LG, CD40L, CD40 Ligand, CD154

CD40 Ligand Protein, Rabbit, Recombinant (E. coli, His)
RHC-CD-1894
20.2 kDa (predicted)
Tumor necrosis factor ligand superfamily member 5, TNLG8B, CD40LG, CD40-L, CD40 ligand

CD40 Ligand Protein, Rabbit, Recombinant (His)
RHC-CD-2081
18.2 kDa (predicted)
Tumor necrosis factor ligand superfamily member 5, TNLG8B, CD40LG, CD40-L, CD40 ligand

CD40 Ligand Protein, Rat, Recombinant (hFc)
RHC-CD-1844
44.4 kDa (predicted); 53 kDa (reducing condition,
CD40 LIGAND

CD40 Ligand Protein, Rhesus, Recombinant (hFc)
RHC-CD-1863
44.7 kDa (predicted)
CD40 LIGAND

CD40 Ligand Trimer Protein, Human, Recombinant (hFc)
RHC-CD-2092
74.9 kDa (predicted). Due to glycosylation, the pr
TRAP, TNFSF5IMD3, TNFSF5, T-BAM, IMD3, IGM, HIGM1, gp39, CD40LIGM, CD40LG, CD40L, CD40 Ligand, CD154

CD40 Ligand/CD154/TRAP1 (Activation Marker of T-Lymphocytes) Monoclonal Antibody (CD40LG/2761), Biotin-Conjugate
BR00001391

CD40 Monoclonal Antibody (1C10), Biotin-Conjugate
BR00000168

CD40 Monoclonal Antibody, Biotin-Conjugate
BR00000890

CD40 Protein, Canine, Recombinant
RHC-CD-0123
19.9 kDa (predicted); 28-32 kDa (reducing conditio
CD40 molecule, TNF receptor superfamily member 5

CD40 Protein, Canine, Recombinant (hFc)
RHC-CD-0122
46.1 kDa (predicted); 50-56 kDa (reducing conditio
CD40 molecule, TNF receptor superfamily member 5

CD40 Protein, Canine, Recombinant (His)
RHC-CD-0069
20.5 kDa (predicted); 33 kDa (reducing condition,
CD40 molecule, TNF receptor superfamily member 5

CD40 Protein, Cynomolgus, Recombinant (hFc)
RHC-CD-0241
48-70 kDa (reducing condition)
Tumor Necrosis Factor Receptor Superfamily member 5, TNFRSF5, CDw40, CD40L Receptor, CD40, Bp50, B-Cell Surface Antigen CD40

CD40 Protein, Cynomolgus, Recombinant (His)
RHC-CD-0055
28-30 kDa (reducing condition)
Tumor Necrosis Factor Receptor Superfamily member 5, TNFRSF5, CDw40, CD40L Receptor, CD40, Bp50, B-Cell Surface Antigen CD40

CD40 Protein, Human, Recombinant (aa 21-193, His & Avi), Biotinylated
RHC-CD-0106
22.1 kDa (predicted). Due to glycosylation, the pr
MGC9013, CDw40, CD40L receptor, CD40 molecule, CD40 antigen, CD40, TNFRSF5

CD40 Protein, Human, Recombinant (hFc & Avi), Biotinylated
RHC-CD-0026
47.7 kDa (predicted)
TNFRSF5, p50, CDW40, CD40 molecule, TNF receptor superfamily member 5, Bp50

CD40 Protein, Human, Recombinant (hFc)
RHC-CD-0121
46.2 kDa (predicted); 54.1 kDa (reducing condition
TNFRSF5, p50, CDW40, CD40 molecule, TNF receptor superfamily member 5, Bp50

CD40 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-0287
22.4 kDa (predicted)
TNFRSF5, p50, CDW40, CD40 molecule, TNF receptor superfamily member 5, Bp50

CD40 Protein, Human, Recombinant (His)
RHC-CD-0083
20.7 kDa (predicted); 32 kDa (reducing condition,
TNFRSF5, p50, CDW40, CD40 molecule, TNF receptor superfamily member 5, Bp50

CD40 Protein, Human, Recombinant (mFc)
RHC-CD-0228
45.5 kDa (predicted)
TNFRSF5, p50, CDW40, CD40 molecule, TNF receptor superfamily member 5, Bp50

CD40 Protein, Mouse, Recombinant (hFc)
RHC-CD-0254
46.4 kDa (predicted)
TRAP, Tnfrsf5, T-BAM, p50, IMD3, IGM, HIGM1, GP39, CD40 molecule, TNF receptor superfamily member 5, Bp50, AI326936

CD40 Protein, Mouse, Recombinant (His & Avi), Biotinylated
RHC-CD-0201
22.5 kDa (predicted)
TRAP, Tnfrsf5, T-BAM, p50, IMD3, IGM, HIGM1, GP39, CD40 molecule, TNF receptor superfamily member 5, Bp50, AI326936

CD40 Protein, Mouse, Recombinant (His)
RHC-CD-0162
20.81 kDa (predicted)
TRAP, Tnfrsf5, T-BAM, p50, IMD3, IGM, HIGM1, GP39, CD40 molecule, TNF receptor superfamily member 5, Bp50, AI326936

CD40 Protein, Mouse, Recombinant (rFc)
RHC-CD-0176
45.4 kDa (predicted)
TRAP, Tnfrsf5, T-BAM, p50, IMD3, IGM, HIGM1, GP39, CD40 molecule, TNF receptor superfamily member 5, Bp50, AI326936

CD40 Protein, Rat, Recombinant (hFc)
RHC-CD-0124
46.2 kDa (predicted); 53 kDa (reducing conditions)
CD40 molecule, TNF receptor superfamily member 5

CD40 Protein, Rat, Recombinant (His)
RHC-CD-0261
20.6 kDa (predicted); 28 kDa (reducing condition,
CD40 molecule, TNF receptor superfamily member 5

CD40 Protein, Rhesus, Recombinant (hFc)
RHC-CD-0173
46.2 kDa (predicted)
CD40 molecule, TNF receptor superfamily member 5

CD40 Protein, Rhesus, Recombinant (His)
RHC-CD-0220
20.7 kDa (predicted)
CD40 molecule, TNF receptor superfamily member 5

CD40:CD40L[Biotinylated] Inhibitor Screening Assay Kit
BR00028170
T cell antigen Gp39, TNF related activation protein, TRAP, tumor necrosis factor ligand superfamily member 5, TNFSF5, CD154, CD40, CD40 Molecule, activity assay kit

CD40L Monoclonal Antibody (MK13A4), Biotin-Conjugate
BR00001590

CD40L Protein, Rhesus macaque, Recombinant (His)
RHC-CD-1906
28.5 kDa (predicted)
Tumor necrosis factor ligand superfamily member 5, TNFSF5, CD40LG, CD40-L, CD40L, CD40 ligand, CD154

CD40L, SOLUBLE HUMAN
IAR42413210

CD40L, SOLUBLE MOUSE
IAR42413211

CD40L/CD154 Monoclonal Antibody (1E6D10), Biotin-Conjugate
BR00001651

CD40LIGAND/TRAP FROM MOUSE
IAR42412945

CD41 Monoclonal Antibody (MEM-06), Biotin-Conjugate
BR00000838

CD41 Monoclonal Antibody (MWReg30), Biotin-Conjugate
BR00000843

CD41/Integrin alpha 2b Monoclonal Antibody (9B10), Biotin-Conjugate
BR00001903

CD41a Monoclonal Antibody (eBioMWReg30 (MWReg30)), Biotin-Conjugate
BR00000130

CD42a/GP9 Protein, Human, Recombinant (hFc)
RHC-CD-3268
41 kDa (predicted). Due to glycosylation, the prot
GP-IX, GPIX, GP9, Glycoprotein 9, CD42a

CD42b Monoclonal Antibody (AK2), Biotin-Conjugate
BR00000845

CD42b/GP1BA Protein, Human, Recombinant (E. coli, His)
RHC-CD-3194
57.9 kDa (predicted)

CD42b/GP1BA Protein, Human, Recombinant (His)
RHC-CD-3141
56.7 kDa (predicted); 93 kDa (reducing condition,
VWDP, GPIb+¦, GPIbalpha, GPIbA, GP1B, glycoprotein Ib (platelet), +¦ polypeptide, glycoprotein Ib (platelet), alpha polypeptide, DBPLT3, CD42b-+¦, CD42b-alpha, CD42B, BSS, BDPLT3, BDPLT1

CD42c Protein, Human, Recombinant (His)
RHC-CD-3099
14.3 kDa (predicted); 20 kDa (reducing condition,
GPIBB, glycoprotein Ib (platelet), +¦ polypeptide, glycoprotein Ib (platelet), beta polypeptide, CD42C, BS, BDPLT1

CD42c Protein, Rat, Recombinant (hFc)
RHC-CD-3155
40.1 kDa (predicted); 63 kDa (reducing conditions)
glycoprotein Ib (platelet), +¦ polypeptide, glycoprotein Ib (platelet), beta polypeptide

CD43 Monoclonal Antibody (eBioR2/60), Biotin-Conjugate
BR00000221

CD43 Monoclonal Antibody (MEM-59), Biotin-Conjugate
BR00000827

CD43 Monoclonal Antibody (W3/13HLK), Biotin-Conjugate
BR00001147

CD43 Protein, Cynomolgus, Recombinant (His)
RHC-CD-2467
24.11 kDa (predicted). Due to glycosylation, the p
SPN, Sialophorin, Ly-48, LSN, Leukosialin, GPL115, Galgp, CD43, A630014B01Rik

CD43 Protein, Human, Recombinant (His)
RHC-CD-2340
24.5 kDa (predicted). Due to glycosylation, the pr
SPN, Sialophorin, Ly-48, LSN, Leukosialin, GPL115, Galgp, CD43, A630014B01Rik

CD43 Protein, Mouse, Recombinant (hFc)
RHC-CD-2008
49.6 kDa (predicted); 110 kDa (reducing condition,
sialophorin, Ly-48, Ly48, Galgp, Cd43, A630014B01Rik

CD43 Protein, Mouse, Recombinant (His)
RHC-CD-2209
23.6 kDa (predicted). Due to glycosylation, the pr
SPN, Sialophorin, Ly-48, LSN, Leukosialin, GPL115, Galgp, CD43, A630014B01Rik

CD43 Protein, Rat, Recombinant (hFc)
RHC-CD-2267
49.3 kDa (predicted); 95, 57 and 50 kDa (reducing
sialophorin

CD437
CAS:125316-60-1
AP125316601
398.49

CD437
CAS:125316-60-1
Formula: C₂₇H₂₆O₃
ACM125316601
398.499

CD437-13C6
Formula: C21*C6H26O3
ACMA00063826
404.45
AHPN-13C6

CD44 Monoclonal Antibody (AV6), Biotin-Conjugate
BR00000921

CD44 Monoclonal Antibody (IM7), Biotin-Conjugate
BR00000100

CD44 Monoclonal Antibody (IM7.8.1), Biotin-Conjugate
BR00000656

CD44 Monoclonal Antibody (KM81), Biotin-Conjugate
BR00000892

CD44 Monoclonal Antibody (MEM-85), Biotin-Conjugate
BR00000723

CD44 Monoclonal Antibody (OTI1D8), Biotin-Conjugate
BR00001842

CD44 Monoclonal Antibody (OTI2E3), Biotin-Conjugate
BR00001840

CD44 Monoclonal Antibody (OTI5B7), Biotin-Conjugate
BR00001843

CD44 Monoclonal Antibody (OTI5D5), Biotin-Conjugate
BR00001841

CD44 Monoclonal Antibody (OX-49), Biotin-Conjugate
BR00000735

CD44 Protein, Cynomolgus, Recombinant (His)
RHC-CD-0112
27.77 kDa (predicted). Due to glycosylation, the p
PGP-I, MIC4, MDU3, MDU2, MC56, LHR, IN, HUTCH-I, HCELL, Epican, ECMR-III, CSPG8, CDw44, CD44

CD44 Protein, Human, Recombinant
RHC-CD-0266
22.07 kDa (predicted); 42.04 kDa (reducing conditi
Pgp1, MIC4, MDU3, MDU2, MC56, LHR, IN, HUTCH-I, HCELL, ECMR-III, CSPG8, CDW44, CD44 molecule (Indian blood group)

CD44 Protein, Human, Recombinant (Avi & mFc), Biotinylated
RHC-CD-0139
51.0 kDa (predicted)
MIC4, MDU3, MDU2, LHR, HUTCH-I, GP90 lymphocyte homing/adhesion receptor, Extracellular matrix receptor III, Epican, ECMR-III, CDw44, CD44 antigen

CD44 Protein, Human, Recombinant (hFc)
RHC-CD-0280
49.1 kDa (predicted); 76 kDa (reducing conditions)
Pgp1, MIC4, MDU3, MDU2, MC56, LHR, IN, HUTCH-I, HCELL, ECMR-III, CSPG8, CDW44, CD44 molecule (Indian blood group)

CD44 Protein, Human, Recombinant (His & SUMO)
RHC-CD-0047
80.2 kDa (predicted)
MIC4, MDU3, MDU2, LHR, HUTCH-I, GP90 lymphocyte homing/adhesion receptor, Extracellular matrix receptor III, Epican, ECMR-III, CDw44, CD44 antigen

CD44 Protein, Human, Recombinant (His)
RHC-CD-0325
23.4 kDa (predicted); 43-48 kDa (reducing conditio
Pgp1, MIC4, MDU3, MDU2, MC56, LHR, IN, HUTCH-I, HCELL, ECMR-III, CSPG8, CDW44, CD44 molecule (Indian blood group)

CD44 Protein, Mouse, Recombinant (His)
RHC-CD-0265
23.6 kDa (predicted)
Pgp-1, Ly-24, HERMES, CD44 molecule (Indian blood group), AW146109, AW121933, AU023126

CD44std Monoclonal Antibody (SFF-2), Biotin-Conjugate
BR00000271

CD44std Monoclonal Antibody (SFF-304), Biotin-Conjugate
BR00000275

CD44var (v3) Monoclonal Antibody (VFF-327v3), Biotin-Conjugate
BR00001119

CD44var (v4) Monoclonal Antibody (VFF-11), Biotin-Conjugate
BR00000812

CD44var (v5) Monoclonal Antibody (VFF-8), Biotin-Conjugate
BR00001110

CD44var (v6) Monoclonal Antibody (VFF-18), Biotin-Conjugate
BR00000813

CD44var (v6) Monoclonal Antibody (VFF-7), Biotin-Conjugate
BR00001111

CD44var (v7) Monoclonal Antibody (VFF-9), Biotin-Conjugate
BR00001112

CD44var (v7-v8) Monoclonal Antibody (VFF-17), Biotin-Conjugate
BR00001113

CD45 ACTIVE HUMAN
IAR42413146

CD45 Monoclonal Antibody (1.11.32), Biotin-Conjugate
BR00001173

CD45 Monoclonal Antibody (14A9), Biotin-Conjugate
BR00001900

CD45 Monoclonal Antibody (30-F11), Biotin-Conjugate
BR00000098

CD45 Monoclonal Antibody (CD45-2B11), Biotin-Conjugate
BR00000054

CD45 Monoclonal Antibody (HI30), Biotin-Conjugate
BR00000028

CD45 Monoclonal Antibody (IBL-5/25), Biotin-Conjugate
BR00000777

CD45 Monoclonal Antibody (LT40), Biotin-Conjugate
BR00000919

CD45 Monoclonal Antibody (MEM-28), Biotin-Conjugate
BR00000708

CD45 Monoclonal Antibody (OX-1), Biotin-Conjugate
BR00000851

CD45 Monoclonal Antibody (OX-30), Biotin-Conjugate
BR00000671

CD45 Monoclonal Antibody (YAML501.4), Biotin-Conjugate
BR00000773

CD45 Monoclonal Antibody (YKIX716.13), Biotin-Conjugate
BR00001146

CD45 Polyclonal Antibody, Biotin-Conjugate
BR00001358

CD45 Protein, Human, Recombinant (aa 1-529, His)
RHC-CD-0058
57.4 kDa (predicted)
T200, protein tyrosine phosphatase, receptor type, C, LY5, L-CA, LCA, GP180, CD45R, CD45, B220

CD45 Protein, Human, Recombinant (aa 26-577, hFc)
RHC-CD-0306
87.53 kDa (predicted). Due to glycosylation, the p
T200, PTPRC, LY5, L-CA, LCA, GP180, EC 3.1.3.48, CD45R, CD45, B220

CD45 Protein, Human, Recombinant (aa 26-577, His)
RHC-CD-0170
62.2 kDa (predicted); 120-170 kDa (reducing condit
T200, protein tyrosine phosphatase, receptor type, C, LY5, L-CA, LCA, GP180, CD45R, CD45, B220

CD45 Protein, Human, Recombinant (hFc)
RHC-CD-0206
71.1 kDa (predicted); 122 kDa (reducing condition,
T200, protein tyrosine phosphatase, receptor type, C, LY5, L-CA, LCA, GP180, CD45R, CD45, B220

CD45 Protein, Human, Recombinant (His & Avi)
RHC-CD-0305
47.3 kDa (predicted). Due to glycosylation, the pr
T200, PTPRC, LY5, L-CA, LCA, GP180, EC 3.1.3.48, CD45R, CD45, B220

CD45 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-0098
47.3 kDa (predicted). Due to glycosylation, the pr
T200, PTPRC, LY5, L-CA, LCA, GP180, EC 3.1.3.48, CD45R, CD45, B220

CD45 Protein, Mouse, Recombinant (aa 453-1152)
RHC-CD-0262
81 kDa (predicted); 93 kDa (reducing conditions)
T200, protein tyrosine phosphatase, receptor type, C, Lyt-4, Ly-5, loc, L-CA, CD45R, Cd45, B220

CD45 Protein, Mouse, Recombinant (aa 453-1152, His & GST)
RHC-CD-0172
108.2 kDa (predicted); 110 kDa (reducing condition
T200, protein tyrosine phosphatase, receptor type, C, Lyt-4, Ly-5, loc, L-CA, CD45R, Cd45, B220

CD45 Protein, Mouse, Recombinant (hFc)
RHC-CD-0065
71.7 kDa (predicted); 118 kDa (reducing condition,
T200, protein tyrosine phosphatase, receptor type, C, Lyt-4, Ly-5, loc, L-CA, CD45R, Cd45, B220

CD45 Protein, Mouse, Recombinant (His)
RHC-CD-0115
120-160 kDa (reducing condition)
receptor-type tyrosine-protein phosphatase C, PTPRC, protein tyrosine phosphatase, receptor type, C, LY5, L-CA, LCA, CD45R, CD45 antigen, CD45, B220

CD45.1 Monoclonal Antibody (A20), Biotin-Conjugate
BR00000153

CD45.2 Monoclonal Antibody (104), Biotin-Conjugate
BR00000142

CD45R (B220) Monoclonal Antibody (HIS24), Biotin-Conjugate
BR00000640

CD45R (B220) Monoclonal Antibody (RA3-6B2), Biotin-Conjugate
BR00000014

CD45R Monoclonal Antibody (YTH80.103), Biotin-Conjugate
BR00000774

CD45RA Monoclonal Antibody (HI100), Biotin-Conjugate
BR00000233

CD45RA Monoclonal Antibody (MEM-56), Biotin-Conjugate
BR00000828

CD45RA Monoclonal Antibody (OX-33), Biotin-Conjugate
BR00000673

CD45RB Monoclonal Antibody (16A), Biotin-Conjugate
BR00000893

CD45RB Monoclonal Antibody (C363.16A), Biotin-Conjugate
BR00000353

CD45RC Monoclonal Antibody (C455.1F), Biotin-Conjugate
BR00001185

CD45RC Monoclonal Antibody (OX-22), Biotin-Conjugate
BR00000691

CD45RO Monoclonal Antibody (UCHL1), Biotin-Conjugate
BR00000096

CD46 HUMAN
IAR42413156

CD46 Monoclonal Antibody (MEM-258), Biotin-Conjugate
BR00000839

CD46 Protein, Canine, Recombinant (His)
RHC-CD-1762
34.11 kDa (predicted). Due to glycosylation, the p
TRA2.10, TLX, MIC10, Membrane cofactor, MCP, LOC609365, CD46, AHUS2

CD46 Protein, Cynomolgus, Recombinant (His)
RHC-CD-1746
34.05 kDa (predicted). Due to glycosylation, the p
TRA2.10, TLX, MIC10, MCP, CD46, AHUS2

CD46 Protein, Human, Recombinant (His)
RHC-CD-1547
34 kDa (predicted); 55-60 kDa (reducing condition,
TRA2.10, TLX, MIC10, MCP, CD46 molecule, complement regulatory protein, AHUS2

CD47 HUMAN
IAR42413182

CD47 Monoclonal Antibody (C10.24), Biotin-Conjugate
BR00001935

CD47 Polyclonal Antibody, Biotin-Conjugate
BR00001425

CD47 Protein, Cynomolgus, Recombinant (hFc)
RHC-CD-1617
40.7 kDa (predicted)
CD47 molecule

CD47 Protein, Cynomolgus, Rhesus, Recombinant (His)
RHC-CD-1354
15.5 kDa (predicted)
CD47 molecule

CD47 Protein, Cynomolgus/Rhesus macaque, Recombinant (His)
RHC-CD-1753
15 kDa (predicted). Due to glycosylation, the prot
OA3, MER6, IAP, CD47 molecule, CD47 glycoprotein, CD47

CD47 Protein, Human, Recombinant
RHC-CD-1395
14.5 kDa (predicted); 35 kDa (reducing condition,
OA3, MER6, IAP, CD47 molecule

CD47 Protein, Human, Recombinant (aa 1-139, His)
RHC-CD-3132
15.2 kDa (predicted); 35-44 kDa (reducing conditio
OA3, MER6, IAP, CD47 molecule

CD47 Protein, Human, Recombinant (aa 19-139, His)
RHC-CD-1412
15.17 kDa (predicted); 34.13 kDa (reducing conditi
OA3, MER6, IAP, CD47 molecule

CD47 Protein, Human, Recombinant (Avi & His), Biotinylated
RHC-CD-1369
30-40 kDa (reducing condition)
Protein MER6, MER6, Leukocyte Surface Antigen CD47, Integrin-Associated Protein, IAP, CD47, Antigenic Surface Determinant Protein OA3

CD47 Protein, Human, Recombinant (hFc & Avi), Biotinylated
RHC-CD-1362
60-70 kDa (reducing condition)
Protein MER6, MER6, Leukocyte Surface Antigen CD47, Integrin-Associated Protein, IAP, CD47, Antigenic Surface Determinant Protein OA3

CD47 Protein, Human, Recombinant (hFc)
RHC-CD-1455
40.7 kDa (predicted); 48-60 kDa (reducing conditio
OA3, MER6, IAP, CD47 molecule

CD47 Protein, Human, Recombinant (His)
RHC-CD-1321
30-45 kDa (reducing condition)
Protein MER6, MER6, Leukocyte Surface Antigen CD47, Integrin-Associated Protein, IAP, CD47, Antigenic Surface Determinant Protein OA3

CD47 Protein, Human, Recombinant (mFc)
RHC-CD-1748
48-65 kDa (reducing condition)
Protein MER6, MER6, Leukocyte Surface Antigen CD47, Integrin-Associated Protein, IAP, CD47, Antigenic Surface Determinant Protein OA3

CD47 Protein, Human, Recombinant, Biotinylated
RHC-CD-1392
14.5 kDa (predicted)
OA3, MER6, IAP, CD47 molecule

CD47 Protein, Mouse, Recombinant
RHC-CD-1393
13.8 kDa (predicted)
Itgp, IAP, CD47 molecule, B430305P08Rik, AW108519, AI848868, AA407862, 9130415E20Rik

CD47 Protein, Mouse, Recombinant (hFc)
RHC-CD-1618
40.6 kDa (predicted)
Itgp, IAP, CD47 molecule, B430305P08Rik, AW108519, AI848868, AA407862, 9130415E20Rik

CD47 Protein, Mouse, Recombinant (His & Avi), Biotinylated
RHC-CD-1605
17.1 kDa (predicted); 38.8 kDa (reducing condition
Itgp, IAP, CD47 molecule, B430305P08Rik, AW108519, AI848868, AA407862, 9130415E20Rik

CD47 Protein, Mouse, Recombinant (His)
RHC-CD-1338
15.3 kDa (predicted); 34-44 kDa (reducing conditio
Itgp, IAP, CD47 molecule, B430305P08Rik, AW108519, AI848868, AA407862, 9130415E20Rik

CD47 Protein, Mouse, Recombinant (rFc)
RHC-CD-1351
39.9 kDa (predicted)
Itgp, IAP, CD47 molecule, B430305P08Rik, AW108519, AI848868, AA407862, 9130415E20Rik

CD47 Protein, Rat, Recombinant (hFc)
RHC-CD-1695
40.8 kDa (predicted); 57-62 kDa (reducing conditio
CD47 molecule

CD47 Protein, Rat, Recombinant (His)
RHC-CD-1560
15.2 kDa (predicted); 27-35 kDa (reducing conditio
CD47 molecule

CD47 Protein, Rhesus macaque, Recombinant (hFc)
RHC-CD-1381
60-90 kDa (reducing condition)
Protein MER6, MER6, Leukocyte Surface Antigen CD47, Integrin-Associated Protein, IAP, CD47, Antigenic Surface Determinant Protein OA3

CD47 Protein, Rhesus macaque, Recombinant (His & Flag)
RHC-CD-1476
33-55 kDa (reducing condition)
Protein MER6, MER6, Leukocyte Surface Antigen CD47, Integrin-Associated Protein, IAP, CD47, Antigenic Surface Determinant Protein OA3

CD47/IAP (Integrin Associated Protein) Monoclonal Antibody (CD47/2937), Biotin-Conjugate
BR00001393

CD47/IAP (Integrin Associated Protein) Monoclonal Antibody (CD47/3019), Biotin-Conjugate
BR00001394

CD47:SIRP-+¦[Biotinylated] Inhibitor Screening Assay Kit
BR00028188
Cluster of Differentiation 47, in Tyrosine-protein phosphatase non-receptor type substrate 1, CD172a, Bit, and MyD-1, integrin associated protein (IAP), activity assay kit

CD47:SIRP-+¦[Biotinylated] Inhibitor Screening Assay Kit
BR00028190
leukocyte surface antigen CD47, Rh-related antigen, integrin-associated protein (IAP), antigenic surface determinant protein OA3, MER6, Signal regulatory protein-gamma, signal regulatory protein beta 2, and CD172g

CD48 Monoclonal Antibody (HM48-1), Biotin-Conjugate
BR00000218

CD48 Monoclonal Antibody (MEM-102), Biotin-Conjugate
BR00000770

CD48 Monoclonal Antibody (OX-45), Biotin-Conjugate
BR00000863

CD48 Protein, Human, Recombinant (hFc & Avi), Biotinylated
RHC-CD-2163
50.88 kDa (predicted); 63.75 kDa (reducing conditi
SLAMF2, MEM-102, mCD48, hCD48, CD48 molecule, Blast-1, BLAST1, BLAST, BCM1

CD48 Protein, Human, Recombinant (hFc)
RHC-CD-1835
49.1 kDa (predicted); 64.5 kDa (reducing condition
SLAMF2, MEM-102, mCD48, hCD48, CD48 molecule, Blast-1, BLAST1, BLAST, BCM1

CD48 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-2437
25.60 kDa (predicted); 42.34 kDa (reducing conditi
SLAMF2, MEM-102, mCD48, hCD48, CD48 molecule, Blast-1, BLAST1, BLAST, BCM1

CD48 Protein, Human, Recombinant (His)
RHC-CD-2242
23.8 kDa (predicted); 40 kDa (reducing condition,
SLAMF2, MEM-102, mCD48, hCD48, CD48 molecule, Blast-1, BLAST1, BLAST, BCM1

CD48 Protein, Mouse, Recombinant (hFc)
RHC-CD-2319
49 kDa (predicted); 63.7 kDa (reducing conditions)
SLAMF2, Sgp-60, MEM-102, CD48 molecule, BLAST-1, BLAST1, BLAST, Bcm-1, BCM1, AW610730, AI449234

CD48 Protein, Mouse, Recombinant (His)
RHC-CD-2004
23.7 kDa (predicted); 45-60 kDa (reducing conditio
SLAMF2, Sgp-60, MEM-102, CD48 molecule, BLAST-1, BLAST1, BLAST, Bcm-1, BCM1, AW610730, AI449234

CD48 Protein, Mouse, Recombinant (His), Biotinylated
RHC-CD-2419
23.7 kDa (predicted); 45.5 kDa (reducing condition
SLAMF2, Sgp-60, MEM-102, CD48 molecule, BLAST-1, BLAST1, BLAST, Bcm-1, BCM1, AW610730, AI449234

CD48 Protein, Rat, Recombinant (hFc)
RHC-CD-2130
49.5 kDa (predicted); 38-44 kDa (reducing conditio
CD48 molecule

CD48 Protein, Rat, Recombinant (His)
RHC-CD-1980
23.9 kDa (predicted); 38-43 kDa (reducing conditio
CD48 molecule

CD48/BCM1/SLAMF2 HUMAN
IAR42413178

CD49b (Integrin alpha 2) Monoclonal Antibody (DX5), Biotin-Conjugate
BR00000200

CD49b (Integrin alpha 2) Monoclonal Antibody (HMa2), Biotin-Conjugate
BR00000618

CD49d (Integrin alpha 4) Monoclonal Antibody (R1-2), Biotin-Conjugate
BR00000485

CD49e (Integrin alpha 5) Monoclonal Antibody (eBioSAM-1 (SAM-1, SAM1)), Biotin-Conjugate
BR00000070

CD49f (Integrin alpha 6) Monoclonal Antibody (eBioGoH3 (GoH3)), Biotin-Conjugate
BR00000134

CD5 HUMAN
IAR42413157

CD5 Monoclonal Antibody (53-7.3), Biotin-Conjugate
BR00000203

CD5 Monoclonal Antibody (CG16), Biotin-Conjugate
BR00000623

CD5 Monoclonal Antibody (f43), Biotin-Conjugate
BR00000938

CD5 Monoclonal Antibody (L17F12), Biotin-Conjugate
BR00000956

CD5 Monoclonal Antibody (OTI10H3), Biotin-Conjugate
BR00001612

CD5 Monoclonal Antibody (OTI2D8), Biotin-Conjugate
BR00001795

CD5 Monoclonal Antibody (OTI2G8), Biotin-Conjugate
BR00001801

CD5 Monoclonal Antibody (OTI3A9), Biotin-Conjugate
BR00001796

CD5 Monoclonal Antibody (OTI5D4), Biotin-Conjugate
BR00001610

CD5 Monoclonal Antibody (OTI9E9), Biotin-Conjugate
BR00001611

CD5 Monoclonal Antibody (OX-19), Biotin-Conjugate
BR00000849

CD5 Monoclonal Antibody (UCHT2), Biotin-Conjugate
BR00000679

CD5 Monoclonal Antibody (YTS121.5.2), Biotin-Conjugate
BR00000897

CD5 Protein (Primary Amine Labeling), Mouse, Recombinant (His), Biotinylated
RHC-CD-0045
38.9 kDa (predicted). Due to glycosylation, the pr
T1, LEU1, CD5 molecule, CD5 antigen, CD5

CD5 Protein, Human, Recombinant (hFc & Avi)
RHC-CD-0238
67.1 kDa (predicted). Due to glycosylation, the pr
T1, LEU1, CD5 molecule, CD5 antigen, CD5

CD5 Protein, Human, Recombinant (hFc & Avi), Biotinylated
RHC-CD-0038
67.1 kDa (predicted). Due to glycosylation, the pr
T1, LEU1, CD5 molecule, CD5 antigen, CD5

CD5 Protein, Human, Recombinant (hFc)
RHC-CD-0093
65.4 kDa (predicted)
T1, LEU1, CD5 molecule

CD5 Protein, Human, Recombinant (His & Avi)
RHC-CD-0200
41.9 kDa (predicted)
T1, LEU1, CD5 molecule

CD5 Protein, Human, Recombinant (His)
RHC-CD-0116
40 kDa (predicted); 48.9 kDa (reducing condition,
T1, LEU1, CD5 molecule

CD5 Protein, Mouse, Recombinant (His)
RHC-CD-0211
39.4 kDa (predicted); 42-48 kDa (reducing conditio
Lyt-1, Ly-A, Ly-12, Ly-1, CD5 molecule

CD5 Protein, Rat, Recombinant (hFc)
RHC-CD-0264
64.5 kDa (predicted); 85 kDa (reducing conditions)
CD5 molecule

CD5 Protein, Rat, Recombinant (His)
RHC-CD-0324
38.9 kDa (predicted); 46-49 kDa (reducing conditio
CD5 molecule

CD5 Protein, Rhesus macaque, Recombinant (His & Avi)
RHC-CD-0240
41.7 kDa (predicted). Due to glycosylation, the pr
T1, LEU1, CD5 molecule, CD5 antigen, CD5

CD5 Protein, Rhesus macaque, Recombinant (His & Avi), Biotinylated
RHC-CD-0292
41.7 kDa (predicted). Due to glycosylation, the pr
T1, LEU1, CD5 molecule, CD5 antigen, CD5

CD50 (ICAM-3) Monoclonal Antibody (CBR-IC3/1), Biotin-Conjugate
BR00000270

CD50 Protein, Human, Recombinant (His & hFc)
RHC-CD-1595
77.2 kDa (predicted); 125-135 kDa (reducing condit
intercellular adhesion molecule 3, ICAM-R, ICAM-3, CDW50, CD50

CD50 Protein, Human, Recombinant (His)
RHC-CD-1331
50.8 kDa (predicted); 100-120 kDa (reducing condit
intercellular adhesion molecule 3, ICAM-R, ICAM-3, CDW50, CD50

CD51 (Integrin alpha V) Monoclonal Antibody (RMV-7), Biotin-Conjugate
BR00000047

CD51/CD61 (Integrin alpha v beta 3) Monoclonal Antibody (23C6), Biotin-Conjugate
BR00000354

CD52 Protein, Cynomolgus, Recombinant (hFc)
RHC-CD-0558
27.82 kDa (predicted)
CD52 molecule

CD52 Protein, Human, Recombinant (hFc & Avi), Biotinylated
RHC-CD-0600
29.7 kDa (predicted)
CDW52, CD52 molecule

CD52 Protein, Human, Recombinant (hFc)
RHC-CD-0609
27.9 kDa (predicted)
CDW52, CD52 molecule

CD52 Protein, Mouse, Recombinant (hFc)
RHC-CD-0403
29 kDa (predicted)
MB7, CLS1, CD52 molecule, CAMPATH-1, B7-Ag, B7, AI463198

CD52 Protein, Rat, Recombinant (hFc)
RHC-CD-0530
31.4 kDa (predicted); 53 kDa (reducing conditions)
CD52 molecule

CD53 Protein, Cynomolgus, Recombinant (aa 107-181, His)
RHC-CD-2131
10.7 kDa (predicted); 19-22 kDa (reducing conditio
CD53 molecule

CD53 Protein, Cynomolgus, Recombinant (aa 107-181, mFc)
RHC-CD-2278
34.9 kDa (predicted); 44 kDa (reducing conditions)
CD53 molecule

CD53 Protein, Mouse, Recombinant (aa 107-181, His)
RHC-CD-2414
10.6 kDa (predicted); 22 kDa (reducing condition,
Tspan25, Ox-44, CD53 molecule, AI323659

CD54 (ICAM-1) Monoclonal Antibody (HA58), Biotin-Conjugate
BR00000045

CD54 (ICAM-1) Monoclonal Antibody (RR1/1), Biotin-Conjugate
BR00000251

CD54 (ICAM-1) Monoclonal Antibody (YN1/1.7.4), Biotin-Conjugate
BR00000471

CD54 Monoclonal Antibody (D3.6), Biotin-Conjugate
BR00002005

CD55 Monoclonal Antibody (MEM-118), Biotin-Conjugate
BR00000732

CD55 Monoclonal Antibody (RIK0-3), Biotin-Conjugate
BR00000872

CD55/DAF HUMAN
IAR42413195

CD55/DAF Protein, Cynomolgus, Recombinant (His)
RHC-CD-1299
35.5 kDa (predicted). Due to glycosylation, the pr
TC, DAF-GPI, Daf1, DAF, CROM, CR, Cd55a, CD55

CD55/DAF Protein, Human, Recombinant (hFc)
RHC-CD-1426
61.7 kDa (predicted); 95-105 kDa (reducing conditi
TC, DAF, CROM, CR, CD55 molecule, decay accelerating factor for complement (Cromer blood group)